CA2253471C - Device for enhancing transdermal sampling - Google Patents
Device for enhancing transdermal sampling Download PDFInfo
- Publication number
- CA2253471C CA2253471C CA002253471A CA2253471A CA2253471C CA 2253471 C CA2253471 C CA 2253471C CA 002253471 A CA002253471 A CA 002253471A CA 2253471 A CA2253471 A CA 2253471A CA 2253471 C CA2253471 C CA 2253471C
- Authority
- CA
- Canada
- Prior art keywords
- agent
- sheet
- microblades
- body surface
- withdrawn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000005070 sampling Methods 0.000 title claims description 55
- 230000002708 enhancing effect Effects 0.000 title description 3
- 210000000434 stratum corneum Anatomy 0.000 claims abstract description 18
- 230000037361 pathway Effects 0.000 claims abstract description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 106
- 210000003491 skin Anatomy 0.000 claims description 40
- 239000012528 membrane Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 20
- 230000003204 osmotic effect Effects 0.000 claims description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 10
- 239000008103 glucose Substances 0.000 claims description 10
- 238000009792 diffusion process Methods 0.000 claims description 9
- 239000003814 drug Substances 0.000 claims description 6
- 238000012544 monitoring process Methods 0.000 claims description 6
- 230000002745 absorbent Effects 0.000 claims description 5
- 239000002250 absorbent Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 5
- 239000011149 active material Substances 0.000 claims description 4
- 239000003792 electrolyte Substances 0.000 claims description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 230000007246 mechanism Effects 0.000 claims description 3
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 claims 2
- 230000004913 activation Effects 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 230000011664 signaling Effects 0.000 claims 1
- 230000001070 adhesive effect Effects 0.000 description 21
- 239000000853 adhesive Substances 0.000 description 19
- 210000004379 membrane Anatomy 0.000 description 16
- 239000000499 gel Substances 0.000 description 13
- 230000004907 flux Effects 0.000 description 10
- 239000010410 layer Substances 0.000 description 10
- 239000000126 substance Substances 0.000 description 8
- 239000000463 material Substances 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 239000012790 adhesive layer Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000005325 percolation Methods 0.000 description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 239000012491 analyte Substances 0.000 description 4
- 238000004873 anchoring Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- -1 polypropylene Polymers 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 150000002739 metals Chemical class 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 210000000282 nail Anatomy 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 239000003961 penetration enhancing agent Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 230000000451 tissue damage Effects 0.000 description 3
- 231100000827 tissue damage Toxicity 0.000 description 3
- 229910052719 titanium Inorganic materials 0.000 description 3
- 239000010936 titanium Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000004821 Contact adhesive Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000005370 electroosmosis Methods 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 239000002117 illicit drug Substances 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 238000003780 insertion Methods 0.000 description 2
- 230000037431 insertion Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910001092 metal group alloy Inorganic materials 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 210000000438 stratum basale Anatomy 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910001069 Ti alloy Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 210000003722 extracellular fluid Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000001640 nerve ending Anatomy 0.000 description 1
- 239000002357 osmotic agent Substances 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000001259 photo etching Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920000193 polymethacrylate Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000005236 sound signal Effects 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 210000000498 stratum granulosum Anatomy 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 238000013271 transdermal drug delivery Methods 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
- A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
- A61B5/1451—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid
- A61B5/14514—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue specially adapted for measuring characteristics of body fluids other than blood for interstitial fluid using means for aiding extraction of interstitial fluid, e.g. microneedles or suction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150015—Source of blood
- A61B5/150022—Source of blood for capillary blood or interstitial fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150053—Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
- A61B5/150061—Means for enhancing collection
- A61B5/150099—Means for enhancing collection by negative pressure, other than vacuum extraction into a syringe by pulling on the piston rod or into pre-evacuated tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150206—Construction or design features not otherwise provided for; manufacturing or production; packages; sterilisation of piercing element, piercing device or sampling device
- A61B5/150274—Manufacture or production processes or steps for blood sampling devices
- A61B5/150282—Manufacture or production processes or steps for blood sampling devices for piercing elements, e.g. blade, lancet, canula, needle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150007—Details
- A61B5/150374—Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
- A61B5/150381—Design of piercing elements
- A61B5/150412—Pointed piercing elements, e.g. needles, lancets for piercing the skin
- A61B5/150427—Specific tip design, e.g. for improved penetration characteristics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150969—Low-profile devices which resemble patches or plasters, e.g. also allowing collection of blood samples for testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/150977—Arrays of piercing elements for simultaneous piercing
- A61B5/150984—Microneedles or microblades
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15103—Piercing procedure
- A61B5/15105—Purely manual piercing, i.e. the user pierces the skin without the assistance of any driving means or driving devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15101—Details
- A61B5/15103—Piercing procedure
- A61B5/15107—Piercing being assisted by a triggering mechanism
- A61B5/15113—Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/15—Devices for taking samples of blood
- A61B5/151—Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
- A61B5/15142—Devices intended for single use, i.e. disposable
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
- A61N1/303—Constructional details
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
- A61B10/0045—Devices for taking samples of body liquids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/20—Surgical instruments, devices or methods, e.g. tourniquets for vaccinating or cleaning the skin previous to the vaccination
- A61B17/205—Vaccinating by means of needles or other puncturing devices
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M2037/0007—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin having means for enhancing the permeation of substances through the epidermis, e.g. using suction or depression, electric or magnetic fields, sound waves or chemical agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0038—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a channel at the side surface
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0046—Solid microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0053—Methods for producing microneedles
Abstract
A device (10, 88, 98, 104) for piercing the stratum corneum of a body surface to form path-ways through which an agent can be withdrawn. The device com-prises: a sheet (6) having a plural-ity of microblades (4) extending downward therefrom for piercing the stratum corneum, and a col-lector (26, 90, 106) on the sheet (6) which withdraws the agent through the pathways.
Description
WO 97/48441 ~ PCTIUS97/10595 ~ DEVICE FOR ENHANCING TRANSDERMAL SAMPLING
The present invention relates to transdermal agent sampling. More 6 particularly, this invention relates to the transdermal sampling of agents, such 7 as glucose, electrolyte and substances of abuse, such as but not limited to 8 alcohol and illicit drugs. The present invention uses skin-piercing microblades 9 to enhance the transdermal flux of the agents during transdermal sampling.
13 Interest in the percutaneous or transdermal sampling of agents 14 continues to grow. The transdermal sampling of agents still faces significant problems. In many instances, the flux of agents through the skin is insufficient 16 to calculate quickly and accurately the concentration of the substance in the 17 blood or body.
18 One method of increasing the transdermal sampling of agents relies on 19 the application of an electric current across the body surface or on "electrotransport". "ElectrotransporN' refers generally to the passage of an 21 agent through a body surface such as skin, mucous membranes, nails, and the 22 like. The transport of the agent is induced or enhanced by the application of an 23 electrical potential, which results in the application of electric current, which 24 samples or enhances sampling of the agent. The electrotransport of agents through a body surface may be attained in various manners. One widely used 26 electrotransport process, iontophoresis, involves the electrically induced 27 transport of charged ions. Electroosmosis, another type of electrotransport 28 process, involves the movement of a solvent with the agent through a 29 membrane under the influence of an electric field. Electroporation, still another type of electrotransport, involves the passage of an agent through pores formed 31 by applying a high voltage electrical pulse to a membrane. In many instances, 1 more than one of these processes may be occurring simultaneously to different 2 extents. Further increases in transdermal sampling rates are highly desirable.
3 One method of increasing the agent transdermal sampling rate involves 4 pre-treating the skin with a skin permeation enhancer. The term "permeation enhancer' is broadly used herein to describe a substance which, when applied 6 to a body surface through which the agent is sampled, enhances its 7 transdermal flux. The mechanism may involve an increase in the permeability 8 of the body surface or in the case of electrotransport sampling a reduction of 9 the electrical resistance of the body surface to the passage of the agent therethrough, and/or the creation of hydrophilic pathways through the body 11 surface during electrotransport.
12 There have been many attempts to enhance transdermal flux by 13 mechanically puncturing the skin prior to transdermal drug delivery. See for 14 example U. S. Patent Nos. 5,279,544 issued to Gross et al., 5,250,023 issued to Lee et al., and 3,964,482 issued to Gerstel et al and WO 96/17648 published 16 June 13, 1996. These devices utilize tubular or cylindrical structures generally, 17 although Gerstel and WO 96/17648 do disclose the use of other shapes, to 18 pierce the outer layer of the skin for agent delivery, but not sampling.
Each of 19 these devices provide manufacturing challenges, limited mechanical attachment of the structure to the skin, and/or undesirable irritation of the skin.
21 As has been discussed, a variety of chemicals and mechanical means 22 have been explored to enhance transdermal flux. However, there is still a need 23 to provide a device suitable for increasing transdermal flux which device is low-24 cost and which can be manufactured reproducibly (i.e., without significant variation from device to device) in high volume production.
AMENDED SI~L
DESCRIPTION OF THE INVENTION
The present invention provides a reproducible, high volume production, low-cost device suitable for increasing transdermal flux for agent sampling and monitoring. The invention comprises a plurality of microblades for piercing the skin. The microblades typically have a length of less than about 0.5 mm and a width and thickness which is even smaller. In spite of their small size, the microblades can be made with an extremely reproducible size and shape so that the microslits formed by the microblades puncturing the skin also have a very reproducible size and depth. Because the microblades have a small thickness (i.e., small relative to the width and length of the blades), the microblades produce less tissue damage for a given cross-section than a skin piercing microneedle having a circular cross-section. The device of the present invention pierces the stratum corneum of a body surface to form pathways through which an agent (e.g., a body electrolyte) can be withdrawn (i.e., sampled or monitored).
In one aspect of the invention, there is provided a device for piercing the stratum corneum of a body surface to form pathways through which an agent can be withdrawn, comprising: a sheet having a plurality of microblades extending downward therefrom; and a collector on the sheet which withdraws the agent through the pathways.
In another aspect of the invention, the device comprises a sheet having a plurality of microblades integral therewith and extending downward therefrom and a collector on the sheet which collects an agent which is withdrawn through the pathways in the skin formed by the microblades.
The device of the present invention can be used in 3a connection with body analyte or drug sampling, or both.
Collectors (i.e., sampling devices) for use with the present invention include, but are not limited to, "reverse"
electrotransport devices as disclosed in Glikfeld et al., U.S. Patent No. 5,279,543 and Guy et al., U.S. Patent No.
13 Interest in the percutaneous or transdermal sampling of agents 14 continues to grow. The transdermal sampling of agents still faces significant problems. In many instances, the flux of agents through the skin is insufficient 16 to calculate quickly and accurately the concentration of the substance in the 17 blood or body.
18 One method of increasing the transdermal sampling of agents relies on 19 the application of an electric current across the body surface or on "electrotransport". "ElectrotransporN' refers generally to the passage of an 21 agent through a body surface such as skin, mucous membranes, nails, and the 22 like. The transport of the agent is induced or enhanced by the application of an 23 electrical potential, which results in the application of electric current, which 24 samples or enhances sampling of the agent. The electrotransport of agents through a body surface may be attained in various manners. One widely used 26 electrotransport process, iontophoresis, involves the electrically induced 27 transport of charged ions. Electroosmosis, another type of electrotransport 28 process, involves the movement of a solvent with the agent through a 29 membrane under the influence of an electric field. Electroporation, still another type of electrotransport, involves the passage of an agent through pores formed 31 by applying a high voltage electrical pulse to a membrane. In many instances, 1 more than one of these processes may be occurring simultaneously to different 2 extents. Further increases in transdermal sampling rates are highly desirable.
3 One method of increasing the agent transdermal sampling rate involves 4 pre-treating the skin with a skin permeation enhancer. The term "permeation enhancer' is broadly used herein to describe a substance which, when applied 6 to a body surface through which the agent is sampled, enhances its 7 transdermal flux. The mechanism may involve an increase in the permeability 8 of the body surface or in the case of electrotransport sampling a reduction of 9 the electrical resistance of the body surface to the passage of the agent therethrough, and/or the creation of hydrophilic pathways through the body 11 surface during electrotransport.
12 There have been many attempts to enhance transdermal flux by 13 mechanically puncturing the skin prior to transdermal drug delivery. See for 14 example U. S. Patent Nos. 5,279,544 issued to Gross et al., 5,250,023 issued to Lee et al., and 3,964,482 issued to Gerstel et al and WO 96/17648 published 16 June 13, 1996. These devices utilize tubular or cylindrical structures generally, 17 although Gerstel and WO 96/17648 do disclose the use of other shapes, to 18 pierce the outer layer of the skin for agent delivery, but not sampling.
Each of 19 these devices provide manufacturing challenges, limited mechanical attachment of the structure to the skin, and/or undesirable irritation of the skin.
21 As has been discussed, a variety of chemicals and mechanical means 22 have been explored to enhance transdermal flux. However, there is still a need 23 to provide a device suitable for increasing transdermal flux which device is low-24 cost and which can be manufactured reproducibly (i.e., without significant variation from device to device) in high volume production.
AMENDED SI~L
DESCRIPTION OF THE INVENTION
The present invention provides a reproducible, high volume production, low-cost device suitable for increasing transdermal flux for agent sampling and monitoring. The invention comprises a plurality of microblades for piercing the skin. The microblades typically have a length of less than about 0.5 mm and a width and thickness which is even smaller. In spite of their small size, the microblades can be made with an extremely reproducible size and shape so that the microslits formed by the microblades puncturing the skin also have a very reproducible size and depth. Because the microblades have a small thickness (i.e., small relative to the width and length of the blades), the microblades produce less tissue damage for a given cross-section than a skin piercing microneedle having a circular cross-section. The device of the present invention pierces the stratum corneum of a body surface to form pathways through which an agent (e.g., a body electrolyte) can be withdrawn (i.e., sampled or monitored).
In one aspect of the invention, there is provided a device for piercing the stratum corneum of a body surface to form pathways through which an agent can be withdrawn, comprising: a sheet having a plurality of microblades extending downward therefrom; and a collector on the sheet which withdraws the agent through the pathways.
In another aspect of the invention, the device comprises a sheet having a plurality of microblades integral therewith and extending downward therefrom and a collector on the sheet which collects an agent which is withdrawn through the pathways in the skin formed by the microblades.
The device of the present invention can be used in 3a connection with body analyte or drug sampling, or both.
Collectors (i.e., sampling devices) for use with the present invention include, but are not limited to, "reverse"
electrotransport devices as disclosed in Glikfeld et al., U.S. Patent No. 5,279,543 and Guy et al., U.S. Patent No.
5,362,307, passive diffusion devices as disclosed in Schoendorfer for U.S. Patent No. 5,438,984, osmotic devices as disclosed in Eckenhoff et al., U.S. Patent No. 4,756,314 and negative pressure driven devices.
~ BRIEF DESCRIPTION OF THE DRAWINGS
3 Figure 1 is a diagrammatic cross-sectional view of a sampling system in 4 accordance with one embodiment of the present invention;
Figure 2 is an enlarged perspective view of the skin proximal side of the 6 micro blade array device which may be used in the present invention;
~ BRIEF DESCRIPTION OF THE DRAWINGS
3 Figure 1 is a diagrammatic cross-sectional view of a sampling system in 4 accordance with one embodiment of the present invention;
Figure 2 is an enlarged perspective view of the skin proximal side of the 6 micro blade array device which may be used in the present invention;
7 Figure 3 is a diagrammatic representation of a method for producing a 8 micro blade array used in the present invention;
9 Figure 4 is a diagrammatic cross-sectional view of a passive agent sampling system in accordance with one embodiment of the present invention;
11 Figure 5 is a diagrammatic cross-sectional view of another embodiment 12 of a passive agent sampling system in accordance with the present invention;
13 Figure 6 is a perspective exploded view of one embodiment of a 14 "reverse" electrotransport agent sampling system with a blade array device according to one embodiment of the present invention;
16 Figure 7 is a bottom plan view of the "reverse" electrotransport agent 17 sampling system of figure 6;
18 Figure 8 is a right side elevational view of the "reverse" electrotransport 19 agent sampling system of figure 6;
Figure 9 is a rear elevational view of the "reverse" electrotransport agent 21 sampling system of figure 6; and 22 Figure 10 is a cross-sectional view taken along line 10-10 of the 23 assembled "reverse" electrotransport agent sampling system of figure 8;
MODES FOR CARRYING OUT THE INVENTION
27 Turning now to the drawings in detail, one embodiment of a sampling 28 device of the present invention is generally shown in Figure 1. Figure 1 29 illustrates an osmotic collector or sampling device 104 in combination with a skin-piercing microblade array member 2. The osmotic collector 104 is 31 attached to a body surface by means of an impermeable flexible adhesive overlay 100. Collector 104 is comprised of an absorbent pad (which is impregnated with an osmotically active material such as a highly soluble salt) 106 located between a semi-permeable or osmotic membrane 94 and an optional agent 5 sensing element 108. The semi-permeable member 94 is permeable to water and the agent to be collected and impermeable to the osmotically active material. Any of a wide variety of natural and synthetic semi-permeable membranes are known in the art as osmotic membranes.
Suitable membranes are enumerated in U.S. Patent Nos.
3,845,770, 3,916,899, 4,077,407 and 4,014,334.
The pad 106 has preferably dispersed therethrough sufficient undissolved osmotic agent such that the concentration of the solution formed within the collection pad as a result of the imbibition of water through the semi-permeable membrane 94 will be maintained at the saturation level throughout the intended sampling period. The pad 106 may also contain dispersed therethrough a collecting material such as colloidal silica, ion exchange resins, activated charcoal or other materials that selectively adhere to the agent being collected to prevent back diffusion of the agent through the membrane 94.
The optional agent sensing element can be any of a variety of chemically reactive sensors and indicators, for example the color indicating test strips associated with glucose testing. The adhesive overlay 100 can have a cut-out or transparent window in the area of the indicators so that the indicators can be readily viewed. In an alternate embodiment, the agent sensing element can be located between the member 2 and the pad 106. Alternatively, pad 106 and osmotic membrane 94 are combined in one layer of absorbent 5a hydrogel that stores the absorbed fluid as well as the agent. Preferably, the pad 106 is free to expand or is encapsulated in the semi-permeable or osmotic membrane 94 so that it retains the fluid therein.
Member 2 is used in conjunction with the percutaneous sampling of an agent. The term "sampling" is used broadly herein to include withdrawal of or monitoring the presence or amount of an agent. The terms "substance"
and "agent" are used interchangeably herein and broadly include substances such s as glucose, body electrolytes, alcohol, illicit drugs, licit substances, 2 pharmaceuticals, blood gases, etc. that can be sampled through the skin. The 3 major barrier properties of the skin, such as resistance to agent passage, reside 4 with the outer most layer (i.e., stratum corneum). The inner division of the epidermis generally comprises three layers commonly identified as stratum 6 granulosum, stratum malpighii, and stratum germinativum. There is essentially 7 little or no resistance to movement of an agent through the stratum granulosum, 8 stratum malpighii, and stratum germinativum. The device of the present 9 invention is used to form microslits in the stratum corneum for in situ sampling of an agent.
11 Member 2 comprises a plurality of microblades 4 (i.e., a blade array) 12 extending downward from one surface of a sheet 6 (see Figure 2 in which a 13 portion of member 2 is in an inverted position to show the microblades).
The 14 microblades 4 are sized and shaped to penetrate the stratum corneum of the epidermis when pressure is applied to the device but do not penetrate the skin 16 sufficiently to contact the patient's nerve endings. With this configuration, the 17 microblades do not cause a painful sensation or bleeding. The microblades 4 18 form microslits in a body surface to increase the sampling of a substance 19 through the body surface. The term "body surface" as used herein refers generally to the skin, of an animal or human. Placement of the member 2 in 21 conjunction with a sampling system associated therewith on the body surface of 22 a patient allows in situ sampling and monitoring without relying on collecting a 23 blood or sample with a needle and syringe or lance and test strip. In one 24 preferred embodiment, the device is designed to monitor glucose levels in diabetic patients. In the case of agent (e.g., body analyte) sampling, the 26 analyte migrates from the body through the microslits in the stratum corneum 27 which are cut by the microblades 4. The sampled agent may be collected 28 directly from the skin, or the agent may be contained in the interstitial fluid 29 and/or sweat of the patient and the latter fluid can be collected for purposes of sampling the agent.
31 In one embodiment, the opening 8 corresponds to the portion of the 2466 CIP 2 =
1 sheet 6 occupied by each of the microblades prior to the blades being 2 transposiiioned into the downward depending position. In the illustrated 3 embodiment (Figures 2 and 3), the sheet 6 is formed with an opening 8 4 between the microblades 4. The opening 8 corresponds to the portion of the sheet 6 occupied by each of the microblades 4 prior to the microblades being 6 bent into a position which is substantially perpendicular to the plane of sheet 6.
7 The number of openings 8 per device and the number of microblades 4 per 8 device are independent. The device may have only one large opening 8 with a 9 plurality of microblades ~ around the opening. As will be described below, the opening 8 may be covered with an agent-attracting member for enhancing the 11 movement of an agent being sampled past the electrodes and into an agent-12 collecting reservoir.
13 The microblades 4 are generally formed from a single piece of material 14 (although they need not be) and are sufficiently sharp and long for puncturing at least the stratum corneum of the body surface. In one embodiment, the 16 microblades 4 and the sheet 6 are essentially impermeable or are impermeable 17 to the passage of an agent. The width of each microblade can be any of a 18 range of widths. Usually, the width of the microblade is in the range of about 25 19 m to 500 m. The length of the microblades is subject to variation of the body surface being penetrated and corresponds to the natural thickness of the 21 stratum corneum. Usually, the microblades 4 will be about 20 m to about 22 m in length. The microblades 4 can have slanted (i.e., angled) leading edges 23 64 (FIG. 2) to further reduce the insertion force required to press the 24 microblades 4 into the body surface. The leading edges 64 of each microblade can be all the same angle or can be at different angles suitable for piercing the 26 body surface. The leading edge can have multiple segments with the distal 27 most segment having a smaller angle with respect to an axis along the length of 28 the microblade than a more proximal segment. Altematively, the leading edge 29 of each microblade can be arcuate (i.e., curved) in shape, having, for example, a convex or concave shape.
31 The member 2 can also improve the attachment of the device to the NME:41DED
~EE~
I body surface so that continuous agent detection through the body surface is 2 preserved during movement of the body surface. In the embodiment shown in 3 FIG. 2, projections in the form of barbs 50 on at least one of the microblades 4 4 assist in anchoring the member 2 and any corresponding device or structure used in combination therewith to the body surface. Barbs 50 can be on any 6 number of the microblades from one to all microblades. The tiarbs 50 are 7 optional as other means for holding the member in contact with the body 8 surface can be used. The present invention can be used in conjunction with a 9 wide variety of microblades configurations, for example, referenoe may be had io to WO 97/48440 published December 24, 1997 of which any of the disclosed I , configurations can be used with the present invention.
12 The pattem for any of the microbiade array members 2 of the present 13 invention can be produced with a photo-etching process. For exaFnple, 14 reference may be had to U.S. Patent No. 6,537,264 of which any of the disclosed methods can be used to produce the 16 member 2 of the present invention. A thin sheet 6 of metal such as stainless 17 steel or titanium is etched photo-lithographicaAy with pattems containing skin 18 piercing structures. In general, a thin laminate dry resist or wet resist is applied 19 on the sheet 6 which typically has a thickness of about 7 pm to about 100 pm, zo preferably about 25 m to about 50 m. The resist is contact exposed using a 21 mask having the desired pattem and is subsequently developed. These n operations are conducted in much the. same way that they are for the 23 manufacture of a printed circuit board. The sheet 6 Is then etched using acidic 24 solutions. After the pattem has been etched through the sheet, the sheet 6 is placed on a die 52 (Figure 3) having a plural'rty of openings 56 corresponding to za the openings 8 in the sheet. A punch 54 having a plurality of protrusions 27 corresponding to the openings 8 in the sheet 6 and openings 56 in the die 52 is za initiaUy located above the sheet 6 and the die 52. At the initial stage, the 29 microblades 4 are in the same plane as the rest of the sheet 6. The punch protrusions 58 are then pressed into the openings 8, thus bending the 31 microblades downward to be substantially perpendicular to the plane of the 1 sheet 6. The finished structure provides microblades 4 with an adjacent 2 opening 8. In one embodiment, the opening 8 allows the passage of interstitial 3 fluid therethrough when the member 2 is applied to the body surface.
4 Rectangular openings 8 are shown in the figures but the invention encompasses the use of any shape openings including, but not limited to, 6 square, triangular, circular and elliptical.
7 Generally, the microblades 4 are at an angle of about 90o to the surface 8 48 (FIG. 2) of the sheet 6 after being punched, but they can be disposed at any 9 angle forward or backward from the perpendicular position that will facilitate penetration of and attachment to the body surface. In addition, other anchoring 11 elements such as barbs, openings, etc. can be used with the angled 12 microblades to further enhance anchoring of the device.
13 The member 2 can optionally be made to adhere to the patient's body 14 surface by various means, including an adhesive applied to the body-contacting side of sheet 6 or other anchoring elements on the member 2 of any of the 16 embodiments discussed herein. Further, a watch band or elastic bandage can 17 be used to maintain the device in contact with the skin. The adhesive should 18 have sufficient tack to insure that the member 2 remains in place on the body 19 surface during normal user activity, and yet permits reasonable removal after the predetermined (e.g., 24-hour) wear period. A suitable release liner (not 21 shown) is preferably provided for maintaining the integrity of the adhesive 22 before use. In use, the release liner is stripped from the adhesive before the 23 device is applied to the skin.
24 As is best shown in Figure 2, the microblades 4 have a thickness which is much smaller than the width of the blades near their base, i.e., near the point 26 where the blades are attached to the sheet 6. This blade geometry provides 27 maximum drug percolation area with a minimum blade penetration area, and 28 hence less tissue damage. The agent percolation area is the area of the micro 29 slit opening(s) formed in the stratum corneum by the blade(s), less the cross-sectional area of the blade(s). The microblades are shaped with the largest 31 possible surface area with a minimal cross-sectional area so as to give the 2466 CIP 2' 1 largest possible percolation area. Thin microblades are better than round 2 protrusions for this purpose because for the same cross-section, a thin blade 3 produces more percolation area and less tissue damage than a round 4 protrusion. This is a crucial advantage over the prior art round elements such 5 as needles and tubes. Thin microblades also require less insertion force than 6 round protrusions. The width of each blade can be any of a range of widths.
7 The widths can be different from blade to blade in the array pattern.
Likewise, 8 the width can be variable along the length of the blade, as will be described in 9 more detail below. The width of the blade at the intersection of the blade and 10 the body surface after the blade array has been inserted is preferably in the 11 range of about 25 m to about 500 m, more preferably about 50 m to about 12 400 m, more preferably 100 m to about 300 m.
11 Figure 5 is a diagrammatic cross-sectional view of another embodiment 12 of a passive agent sampling system in accordance with the present invention;
13 Figure 6 is a perspective exploded view of one embodiment of a 14 "reverse" electrotransport agent sampling system with a blade array device according to one embodiment of the present invention;
16 Figure 7 is a bottom plan view of the "reverse" electrotransport agent 17 sampling system of figure 6;
18 Figure 8 is a right side elevational view of the "reverse" electrotransport 19 agent sampling system of figure 6;
Figure 9 is a rear elevational view of the "reverse" electrotransport agent 21 sampling system of figure 6; and 22 Figure 10 is a cross-sectional view taken along line 10-10 of the 23 assembled "reverse" electrotransport agent sampling system of figure 8;
MODES FOR CARRYING OUT THE INVENTION
27 Turning now to the drawings in detail, one embodiment of a sampling 28 device of the present invention is generally shown in Figure 1. Figure 1 29 illustrates an osmotic collector or sampling device 104 in combination with a skin-piercing microblade array member 2. The osmotic collector 104 is 31 attached to a body surface by means of an impermeable flexible adhesive overlay 100. Collector 104 is comprised of an absorbent pad (which is impregnated with an osmotically active material such as a highly soluble salt) 106 located between a semi-permeable or osmotic membrane 94 and an optional agent 5 sensing element 108. The semi-permeable member 94 is permeable to water and the agent to be collected and impermeable to the osmotically active material. Any of a wide variety of natural and synthetic semi-permeable membranes are known in the art as osmotic membranes.
Suitable membranes are enumerated in U.S. Patent Nos.
3,845,770, 3,916,899, 4,077,407 and 4,014,334.
The pad 106 has preferably dispersed therethrough sufficient undissolved osmotic agent such that the concentration of the solution formed within the collection pad as a result of the imbibition of water through the semi-permeable membrane 94 will be maintained at the saturation level throughout the intended sampling period. The pad 106 may also contain dispersed therethrough a collecting material such as colloidal silica, ion exchange resins, activated charcoal or other materials that selectively adhere to the agent being collected to prevent back diffusion of the agent through the membrane 94.
The optional agent sensing element can be any of a variety of chemically reactive sensors and indicators, for example the color indicating test strips associated with glucose testing. The adhesive overlay 100 can have a cut-out or transparent window in the area of the indicators so that the indicators can be readily viewed. In an alternate embodiment, the agent sensing element can be located between the member 2 and the pad 106. Alternatively, pad 106 and osmotic membrane 94 are combined in one layer of absorbent 5a hydrogel that stores the absorbed fluid as well as the agent. Preferably, the pad 106 is free to expand or is encapsulated in the semi-permeable or osmotic membrane 94 so that it retains the fluid therein.
Member 2 is used in conjunction with the percutaneous sampling of an agent. The term "sampling" is used broadly herein to include withdrawal of or monitoring the presence or amount of an agent. The terms "substance"
and "agent" are used interchangeably herein and broadly include substances such s as glucose, body electrolytes, alcohol, illicit drugs, licit substances, 2 pharmaceuticals, blood gases, etc. that can be sampled through the skin. The 3 major barrier properties of the skin, such as resistance to agent passage, reside 4 with the outer most layer (i.e., stratum corneum). The inner division of the epidermis generally comprises three layers commonly identified as stratum 6 granulosum, stratum malpighii, and stratum germinativum. There is essentially 7 little or no resistance to movement of an agent through the stratum granulosum, 8 stratum malpighii, and stratum germinativum. The device of the present 9 invention is used to form microslits in the stratum corneum for in situ sampling of an agent.
11 Member 2 comprises a plurality of microblades 4 (i.e., a blade array) 12 extending downward from one surface of a sheet 6 (see Figure 2 in which a 13 portion of member 2 is in an inverted position to show the microblades).
The 14 microblades 4 are sized and shaped to penetrate the stratum corneum of the epidermis when pressure is applied to the device but do not penetrate the skin 16 sufficiently to contact the patient's nerve endings. With this configuration, the 17 microblades do not cause a painful sensation or bleeding. The microblades 4 18 form microslits in a body surface to increase the sampling of a substance 19 through the body surface. The term "body surface" as used herein refers generally to the skin, of an animal or human. Placement of the member 2 in 21 conjunction with a sampling system associated therewith on the body surface of 22 a patient allows in situ sampling and monitoring without relying on collecting a 23 blood or sample with a needle and syringe or lance and test strip. In one 24 preferred embodiment, the device is designed to monitor glucose levels in diabetic patients. In the case of agent (e.g., body analyte) sampling, the 26 analyte migrates from the body through the microslits in the stratum corneum 27 which are cut by the microblades 4. The sampled agent may be collected 28 directly from the skin, or the agent may be contained in the interstitial fluid 29 and/or sweat of the patient and the latter fluid can be collected for purposes of sampling the agent.
31 In one embodiment, the opening 8 corresponds to the portion of the 2466 CIP 2 =
1 sheet 6 occupied by each of the microblades prior to the blades being 2 transposiiioned into the downward depending position. In the illustrated 3 embodiment (Figures 2 and 3), the sheet 6 is formed with an opening 8 4 between the microblades 4. The opening 8 corresponds to the portion of the sheet 6 occupied by each of the microblades 4 prior to the microblades being 6 bent into a position which is substantially perpendicular to the plane of sheet 6.
7 The number of openings 8 per device and the number of microblades 4 per 8 device are independent. The device may have only one large opening 8 with a 9 plurality of microblades ~ around the opening. As will be described below, the opening 8 may be covered with an agent-attracting member for enhancing the 11 movement of an agent being sampled past the electrodes and into an agent-12 collecting reservoir.
13 The microblades 4 are generally formed from a single piece of material 14 (although they need not be) and are sufficiently sharp and long for puncturing at least the stratum corneum of the body surface. In one embodiment, the 16 microblades 4 and the sheet 6 are essentially impermeable or are impermeable 17 to the passage of an agent. The width of each microblade can be any of a 18 range of widths. Usually, the width of the microblade is in the range of about 25 19 m to 500 m. The length of the microblades is subject to variation of the body surface being penetrated and corresponds to the natural thickness of the 21 stratum corneum. Usually, the microblades 4 will be about 20 m to about 22 m in length. The microblades 4 can have slanted (i.e., angled) leading edges 23 64 (FIG. 2) to further reduce the insertion force required to press the 24 microblades 4 into the body surface. The leading edges 64 of each microblade can be all the same angle or can be at different angles suitable for piercing the 26 body surface. The leading edge can have multiple segments with the distal 27 most segment having a smaller angle with respect to an axis along the length of 28 the microblade than a more proximal segment. Altematively, the leading edge 29 of each microblade can be arcuate (i.e., curved) in shape, having, for example, a convex or concave shape.
31 The member 2 can also improve the attachment of the device to the NME:41DED
~EE~
I body surface so that continuous agent detection through the body surface is 2 preserved during movement of the body surface. In the embodiment shown in 3 FIG. 2, projections in the form of barbs 50 on at least one of the microblades 4 4 assist in anchoring the member 2 and any corresponding device or structure used in combination therewith to the body surface. Barbs 50 can be on any 6 number of the microblades from one to all microblades. The tiarbs 50 are 7 optional as other means for holding the member in contact with the body 8 surface can be used. The present invention can be used in conjunction with a 9 wide variety of microblades configurations, for example, referenoe may be had io to WO 97/48440 published December 24, 1997 of which any of the disclosed I , configurations can be used with the present invention.
12 The pattem for any of the microbiade array members 2 of the present 13 invention can be produced with a photo-etching process. For exaFnple, 14 reference may be had to U.S. Patent No. 6,537,264 of which any of the disclosed methods can be used to produce the 16 member 2 of the present invention. A thin sheet 6 of metal such as stainless 17 steel or titanium is etched photo-lithographicaAy with pattems containing skin 18 piercing structures. In general, a thin laminate dry resist or wet resist is applied 19 on the sheet 6 which typically has a thickness of about 7 pm to about 100 pm, zo preferably about 25 m to about 50 m. The resist is contact exposed using a 21 mask having the desired pattem and is subsequently developed. These n operations are conducted in much the. same way that they are for the 23 manufacture of a printed circuit board. The sheet 6 Is then etched using acidic 24 solutions. After the pattem has been etched through the sheet, the sheet 6 is placed on a die 52 (Figure 3) having a plural'rty of openings 56 corresponding to za the openings 8 in the sheet. A punch 54 having a plurality of protrusions 27 corresponding to the openings 8 in the sheet 6 and openings 56 in the die 52 is za initiaUy located above the sheet 6 and the die 52. At the initial stage, the 29 microblades 4 are in the same plane as the rest of the sheet 6. The punch protrusions 58 are then pressed into the openings 8, thus bending the 31 microblades downward to be substantially perpendicular to the plane of the 1 sheet 6. The finished structure provides microblades 4 with an adjacent 2 opening 8. In one embodiment, the opening 8 allows the passage of interstitial 3 fluid therethrough when the member 2 is applied to the body surface.
4 Rectangular openings 8 are shown in the figures but the invention encompasses the use of any shape openings including, but not limited to, 6 square, triangular, circular and elliptical.
7 Generally, the microblades 4 are at an angle of about 90o to the surface 8 48 (FIG. 2) of the sheet 6 after being punched, but they can be disposed at any 9 angle forward or backward from the perpendicular position that will facilitate penetration of and attachment to the body surface. In addition, other anchoring 11 elements such as barbs, openings, etc. can be used with the angled 12 microblades to further enhance anchoring of the device.
13 The member 2 can optionally be made to adhere to the patient's body 14 surface by various means, including an adhesive applied to the body-contacting side of sheet 6 or other anchoring elements on the member 2 of any of the 16 embodiments discussed herein. Further, a watch band or elastic bandage can 17 be used to maintain the device in contact with the skin. The adhesive should 18 have sufficient tack to insure that the member 2 remains in place on the body 19 surface during normal user activity, and yet permits reasonable removal after the predetermined (e.g., 24-hour) wear period. A suitable release liner (not 21 shown) is preferably provided for maintaining the integrity of the adhesive 22 before use. In use, the release liner is stripped from the adhesive before the 23 device is applied to the skin.
24 As is best shown in Figure 2, the microblades 4 have a thickness which is much smaller than the width of the blades near their base, i.e., near the point 26 where the blades are attached to the sheet 6. This blade geometry provides 27 maximum drug percolation area with a minimum blade penetration area, and 28 hence less tissue damage. The agent percolation area is the area of the micro 29 slit opening(s) formed in the stratum corneum by the blade(s), less the cross-sectional area of the blade(s). The microblades are shaped with the largest 31 possible surface area with a minimal cross-sectional area so as to give the 2466 CIP 2' 1 largest possible percolation area. Thin microblades are better than round 2 protrusions for this purpose because for the same cross-section, a thin blade 3 produces more percolation area and less tissue damage than a round 4 protrusion. This is a crucial advantage over the prior art round elements such 5 as needles and tubes. Thin microblades also require less insertion force than 6 round protrusions. The width of each blade can be any of a range of widths.
7 The widths can be different from blade to blade in the array pattern.
Likewise, 8 the width can be variable along the length of the blade, as will be described in 9 more detail below. The width of the blade at the intersection of the blade and 10 the body surface after the blade array has been inserted is preferably in the 11 range of about 25 m to about 500 m, more preferably about 50 m to about 12 400 m, more preferably 100 m to about 300 m.
13 The sheet 6 and microblades 4 can be made from materials that have 14 sufficient strength and manufacturability to produce blades, such as, glasses, ceramics, rigid polymers, metals and metal alloys. Examples of metals and 16 metal alloys include but are not limited to stainless steel, iron, steel, tin, zinc, 17 copper, platinum, aluminum, germanium, nickel, zirconium, titanium and 18 titanium alloys consisting of nickel, molybdenum and chromium, metals plated 19 with nickel, gold, rhodium, iridium, titanium, platinum, and the like. An example of glasses include a devitrified glass such as "PHOTOCERAM" available from 21 Coming in Coming, NY. Examples of polymers include but are not limited to 22 rigid polymers such as polystyrene, polymethylmethacrylate, polypropylene, 23 polyethylene, "BAKELITE", cellulose acetate, ethyl cellulose, 24 styrene/acrylonitrile copolymers, styrene/butadiene copolymers, acrylonitrile/butadiene/styrene (ABS) copolymers, polyvinyl chloride and acrylic 26 acid polymers including polyacrylates and polymethacrylates.
27 The number of microblades 4 and openings 8 of any of the 28 embodiments of the member 2 is variable with respect to the desired flux rate, 29 agent being sampled, sampling device used (i.e., reverse electrotransport, passive diffusion, osmotic, suction, etc.), and other factors as will be evident to 31 one of ordinary skill in the art. In general, the larger the number of blades per ~~~
, unit area (i.e., the blade density), the more distributed is the flux of the agent 2 through the skin because there are a greater number of agent-conveying 3 pathways through the skin. Consequently, the smaller the number of blades 4 per unit area, the more concentrated is the flux of the agent through the skin because there are fewer pathways. The present invention has a blade density 6 of at least about 10 blades/cm2 and less than about 1000 blades/cm2, 7 preferably at least about 600 blades/cmZ, more preferably at least about 800 8 blades/cm2. In similar fashion, the number of openings per unit area through 9 which the agent passes is at least about 10 openings/cm2 and less than about 1000 openings/cm2. In one embodiment, the present invention produces a 11 percolation area of about 0.005 to .05 cm2/cm2 of body surface, preferably 12 about 0.01 cm2/cm2 of body surface.
13 In other embodiments of the present invention, passive transdermal 14 sampling devices are used with member 2. Two examples of passive transdermal sampling devices are illustrated in Figures 4 and 5. In Figure 4, 16 passive transdermal sampling device 88 comprises a reservoir 90 sandwiched 17 between a backing layer 92, which is preferably impermeable to the agent, and 18 a wicking membrane 94. In Figure 4, the reservoir 90 is formed of a material, 19 such as a rubbery polymer, that is sufficiently viscous to maintain its shape. If a lower viscosity material is used for reservoir 90, such as an aqueous gel, 21 backing layer 92 and wicking membrane 94 would be sealed together about 22 their periphery to prevent leakage. Located below membrane 94 is microblade 23 array member 2. The device 88 adheres to a body surface by means of 24 contact adhesive layer 96 around the periphery of the member 2. A
strippable release liner (not shown) is normally provided along the exposed surface of 26 adhesive layer 96 and is removed prior to application of device 88 to the body 27 surface.
28 Alternatively, as shown in Figure 5, transdermal sampling device 98 may 29 be attached to a body surface by means of a flexible adhesive overlay 100.
Device 98 is comprised of an impermeable backing layer 102 adjacent one 31 surface of reservoir 90. Adhesive overlay 100 maintains the device 98 on the 1 body surface. Adhesive overlay 100 can be fabricated together with, or 2 provided separately from, the remaining elements of the device 98. With 3 certain formulations, the adhesive overlay 100 may be preferable to the contact 4 adhesive 96 shown in Figure 4. This is true, for example, where the agent reservoir contains a material (such as, for example, an oily surfactant 6 permeation enhancer) which adversely affects the adhesive properties of the 7 contact adhesive layer 96. Impermeable backing layer 102 is preferably slightly 8 larger than reservoir 90, and in this manner prevents the agent collected in 9 reservoir 90 from adversely interacting with the adhesive in overlay 100. A
wicking membrane (not shown in Figure 5) similar to membrane 94 in device 88 11 (Figure 4) is located on the skin/mucosa side of reservoir 90. A strippable 12 release liner (not shown) is also normally provided with device 98 and is 13 removed just prior to application of device 98 to the body surface.
14 One embodiment of the present invention relies on the application of an electric current across the body surface or "electrotransport".
Electrotransport 16 refers generally to the passage of an agent through a body surface such as 17 skin, mucous membranes, nails, and the like. The transport of the agent is 18 induced or enhanced by the application of an electrical potential, which results 19 in the application of electric current, which for "reverse"
electrotransport, samples or enhances sampling of the agent. The electrotransport of the agents 21 out of the skin may be aitained in various manners. One widely used 22 electrotransport process, iontophoresis, involves the electrically induced 23 transport of charged ions. Electroosmosis, another type of electrotransport 24 process invloved in the transdermal transport of uncharged or neutrally charged molecules (e.g., transdermal sampling of glucose), involves the movement of a 26 solvent with the agent through a membrane under the influence of an electric 27 field. Electroporation, still another type of electrotransport, involves the 28 passage of an agent through pores formed by applying an electrical pulse, a 29 high voltage pulse, to the skin. In many instances, more than one of these processes may be occurring simultaneously to different extents. Accordingly, 31 the term "electrotransport" is given herein its broadest possible interpretation, to 1 include the electrically induced or enhanced transport of at least one charged or 2 uncharged agent, or mixtures thereof, regardless of the specific mechanism(s) 3 by which the agent is actually being transported.
4 It will be appreciated by those working in the field that the present invention can be used in conjunction with a wide variety of electrotransport 6 systems, as the invention is not limited in any way in this regard. For examples 7 of electrotransport drug sampling systems, reference may be had to U.S.
8 Patent Nos. 5,279,543 to Glikfeld et al. and 5,362,307 to Guy et al.
9 Electrotransport devices generally Lise at least two electrodes which are in elPctrical contact with some portion of the skin, nails, mucous membranes, or 11 other body surface. In the case of transdermal agent sampling, one of the two 12 electrodes is referred to as the "receptor" electrode, and is the one into which 13 the agent (e.g., body analyte) is collected after being withdrawn from the body.
14 The second electrode is typically termed the "counter" or "return"
electrode, and serves to close the electrical circuit through the body. For example, when the 16 agent to be sampled is a cation, the cathode becomes the receptor electrode 17 while the anode serves to complete the circuit. When the agent to be sampled 18 is an anion, the anode becomes the receptor electrode while the cathode 19 serves to complete the circuit. When the agent to be sampled has no net charge (e.g., glucose), then either the anode or the cathode, or both electrodes, 21 can serve as the receptor electrode.
22 Figures 6-10 illustrate a representative reverse electrotransport sampling 23 device 10 that may be used in conjunction with the present invention.
Device 24 10 comprises an upper housing 16, a circuit board assembly 18, a lower housing 20, first electrode 22, second electrode 24, electrically conductive gel 26 reservoir 26, electrically conductive gel reservoir 28 and skin-compatible 27 adhesive 30. Upper housing 16 has lateral wings 15 which assist in holding 28 device 10 on a patient's skin. Printed circuit board assembly 18 comprises an 29 integrated circuit 19 coupled to discrete components 40 and battery 32.
Circuit board assembly 18 is attached to housing 16 by posts (not shown in Figure 1) s.
~~~~
1 passing through openings 13a and 13b, the ends of the posts being 2 heated/melted in order to heat stake the circuit board assembly 18 to the 3 housing 16. Lower housing 20 is attached to the upper housing 16 by means 4 of adhesive layer 30, the upper surface 34 of adhesive layer 30 being adhered to both lower housing 20 and upper housing 16 including the bottom surfaces 6 of wings 15. Shown (partially) on the underside of circuit board assembly 18 is 7 a button cell battery 32. Other types of batteries may also be employed to 8 power device 10 depending on the need.
9 The device 10 is generally comprised of battery 32, eiectronic circuitry 19,40, electrodes 22,24, conductive gel reservoirs 26,28, and device 2, all of 11 which are integrated into a self-contained unit. The outputs (not shown in 12 Figure 1) of the circuit board assembly 18 make electrical contact with the 13 electrodes 24 and 22 through openings 23,23 in the depressions 25,25' formed 14 in lower housing 20, by means of electrically conductive adhesive strips 42,42'.
Eiectrodes 22 and 24, in turn, are in direct mechanical and electrical contact 16 with the top sides 44,44 of conductive gel reservoirs 26 and 28. The bottom 17 side 46 of conductive gel reservoir 28 contacts the patient's skin through the 18 opening 29 in adhesive layer 30. The bottom side 46' of conductive gel 19 reservoir 26 contacts the patient's skin through the plurality of openings 8 in the device 2. The gel in reservoir 26 is preferably a viscous gel that fills the 21 openings 8 such that the gel is in contact with the skin when the blades have 22 penetrated the stratum corneum. The contact between the gel and skin 23 provides a path for the agent to be transported along. If the gel is not in direct 24 contact with the skin initially, typically sweat accumulates in the confined area and provides a path for the transport of agent from the skin.
26 Device 10 optionally has a feature which allows the patient to 27 self-administer a sampling or monitoring sequence. Upon depression of push 28 button switch 12, the electronic circuitry on circuit board assembly 18 delivers a 29 predetermined DC current to the electrode/reservoirs 22,26 and 24,28 for a sampling interval of predetermined length. The push button switch 12 is 31 conveniently located on the top side of device 10 and is easily actuated through I clothing. A double press of the push button switch 12 within a short time 2 period, e.g., three seconds, is preferably used to activate the device for a 3 sampling or monitoring sequence, thereby minimizing the likelihood of 4 inadvertent actuation of the device 10. Preferably, the device transmits to the user a visual and/or audible confirmation of the onset of the sampling interval 6 by means of LED 14 becoming lit and/or an audible sound signal from, e.g., a 7 "beeper". Agent is withdrawn through the patient's skin, e.g., on the arm, by 8 electrotransport over the predetermined sampling interval.
s The push button switch 12, the electronic circuitry on circuit board to assembly 18 and the battery 32 are adhesively "sealed" between upper 11 housing 16 and lower housing 20. Upper housing 16 is preferably composed of 12 rubber or other elastomeric material, e.g., injection moldable ethylene vinyl 13 acetate. Lower housing 20 is preferably composed of a plastic or elastomeric 14 sheet rnaterial (e.g., polyethylene) which can be easily molded to form depressions 25,25' and cut to form openings 23,23'. The assembled device 10 16 is preferably water resistant (i.e., splash proof) and is most preferably 17 waterproof. The system has a low profile that easily conforms to the body, 18 thereby allowing freedom of movement at, and around, the wearing site. The 19 reservoirs 26 and 28 are located on the skin-contacting side of the device and are sufficiently separated to prevent accidental electrical shorting during 21 normal handling and use.
22 The device 10 adheres to the patient's body surface (e.g., skin) by 23 means of an adhesive layer 30 (which has upper adhesive side 34 and body-24 contacting adhesive side 36). The adhesive side 36 covers the entire underneath side of the device 10 except where the device 2 and reservoir 28 26 are located. The adhesive side 36 has adhesive properties which assures that 27 the device 10 remains in place on the body during normal user activity, and yet 28 permits reasonable removal after the predetermined (e.g., 24-hour) wear 29 period. Upper adhesive side 34 adheres to lower housing 20 and retains the electrodes and gel reservoirs within housing depression 25,25' as well as 31 retains device 2 to lower housing 20 and lower housing 20 to upper housing 16.
I In one embodiment of the sampling device, there is a release liner (not shown) 2 on the device 10 for maintaining the integrity of the device when it is not in use.
3 In use, the release liner is stripped from the device before the device is applied 4 to the skin.
The preferred form in which an agent is sampled generally determines 6 the type of sampling system to be used. That is, the selection of a "passive"
7 system which samples the agent by diffusion or an electrically powered system 8 which samples the agent by electrotransport will be mostly determined by the 9 form of the agent. For osmotic systems which sample drugs by convective flow carried by a solvent, the agent preferably has sufficient solubility in the carrier õ solvent. It will be appreciated by those working in the field that the present 12 invention can be used in conjunction with a wide variety of osmotic sampling 13 systems, as the invention is not limited to a particular device in this regard.
14 Osmotic devices are disclosed for example in U.S. Patent Nos. 4,756,314 to Eckenhoff et al., 4,340,480 to Eckenhoff, 4,655,766 to Theeuwes et al., and 16 4,753,651 to Eckenhoff. As mentioned above, the member 2 of the present 17 invention can be used with known sampling devices including, but not limited 18 to, reverse iontophoresis, osmosis, passive diffusion, phonophoresis, and 19 suction (i.e., negative pressure).
It will be appreciated by those of ordinary skill in the art that the invention 21 can be embodied in other specific forms without departing from the spirit or 22 essential character thereof. The presently disclosed embodiments are 23 therefore considered in all respects to be illustrative and not restrictive. The 24 scope of the invention is indicated by the appended claims rather than the foregoing description, and all changes which come within the meaning and 26 range of equivalents thereof are intended to be embraced therein.
- "~
27 The number of microblades 4 and openings 8 of any of the 28 embodiments of the member 2 is variable with respect to the desired flux rate, 29 agent being sampled, sampling device used (i.e., reverse electrotransport, passive diffusion, osmotic, suction, etc.), and other factors as will be evident to 31 one of ordinary skill in the art. In general, the larger the number of blades per ~~~
, unit area (i.e., the blade density), the more distributed is the flux of the agent 2 through the skin because there are a greater number of agent-conveying 3 pathways through the skin. Consequently, the smaller the number of blades 4 per unit area, the more concentrated is the flux of the agent through the skin because there are fewer pathways. The present invention has a blade density 6 of at least about 10 blades/cm2 and less than about 1000 blades/cm2, 7 preferably at least about 600 blades/cmZ, more preferably at least about 800 8 blades/cm2. In similar fashion, the number of openings per unit area through 9 which the agent passes is at least about 10 openings/cm2 and less than about 1000 openings/cm2. In one embodiment, the present invention produces a 11 percolation area of about 0.005 to .05 cm2/cm2 of body surface, preferably 12 about 0.01 cm2/cm2 of body surface.
13 In other embodiments of the present invention, passive transdermal 14 sampling devices are used with member 2. Two examples of passive transdermal sampling devices are illustrated in Figures 4 and 5. In Figure 4, 16 passive transdermal sampling device 88 comprises a reservoir 90 sandwiched 17 between a backing layer 92, which is preferably impermeable to the agent, and 18 a wicking membrane 94. In Figure 4, the reservoir 90 is formed of a material, 19 such as a rubbery polymer, that is sufficiently viscous to maintain its shape. If a lower viscosity material is used for reservoir 90, such as an aqueous gel, 21 backing layer 92 and wicking membrane 94 would be sealed together about 22 their periphery to prevent leakage. Located below membrane 94 is microblade 23 array member 2. The device 88 adheres to a body surface by means of 24 contact adhesive layer 96 around the periphery of the member 2. A
strippable release liner (not shown) is normally provided along the exposed surface of 26 adhesive layer 96 and is removed prior to application of device 88 to the body 27 surface.
28 Alternatively, as shown in Figure 5, transdermal sampling device 98 may 29 be attached to a body surface by means of a flexible adhesive overlay 100.
Device 98 is comprised of an impermeable backing layer 102 adjacent one 31 surface of reservoir 90. Adhesive overlay 100 maintains the device 98 on the 1 body surface. Adhesive overlay 100 can be fabricated together with, or 2 provided separately from, the remaining elements of the device 98. With 3 certain formulations, the adhesive overlay 100 may be preferable to the contact 4 adhesive 96 shown in Figure 4. This is true, for example, where the agent reservoir contains a material (such as, for example, an oily surfactant 6 permeation enhancer) which adversely affects the adhesive properties of the 7 contact adhesive layer 96. Impermeable backing layer 102 is preferably slightly 8 larger than reservoir 90, and in this manner prevents the agent collected in 9 reservoir 90 from adversely interacting with the adhesive in overlay 100. A
wicking membrane (not shown in Figure 5) similar to membrane 94 in device 88 11 (Figure 4) is located on the skin/mucosa side of reservoir 90. A strippable 12 release liner (not shown) is also normally provided with device 98 and is 13 removed just prior to application of device 98 to the body surface.
14 One embodiment of the present invention relies on the application of an electric current across the body surface or "electrotransport".
Electrotransport 16 refers generally to the passage of an agent through a body surface such as 17 skin, mucous membranes, nails, and the like. The transport of the agent is 18 induced or enhanced by the application of an electrical potential, which results 19 in the application of electric current, which for "reverse"
electrotransport, samples or enhances sampling of the agent. The electrotransport of the agents 21 out of the skin may be aitained in various manners. One widely used 22 electrotransport process, iontophoresis, involves the electrically induced 23 transport of charged ions. Electroosmosis, another type of electrotransport 24 process invloved in the transdermal transport of uncharged or neutrally charged molecules (e.g., transdermal sampling of glucose), involves the movement of a 26 solvent with the agent through a membrane under the influence of an electric 27 field. Electroporation, still another type of electrotransport, involves the 28 passage of an agent through pores formed by applying an electrical pulse, a 29 high voltage pulse, to the skin. In many instances, more than one of these processes may be occurring simultaneously to different extents. Accordingly, 31 the term "electrotransport" is given herein its broadest possible interpretation, to 1 include the electrically induced or enhanced transport of at least one charged or 2 uncharged agent, or mixtures thereof, regardless of the specific mechanism(s) 3 by which the agent is actually being transported.
4 It will be appreciated by those working in the field that the present invention can be used in conjunction with a wide variety of electrotransport 6 systems, as the invention is not limited in any way in this regard. For examples 7 of electrotransport drug sampling systems, reference may be had to U.S.
8 Patent Nos. 5,279,543 to Glikfeld et al. and 5,362,307 to Guy et al.
9 Electrotransport devices generally Lise at least two electrodes which are in elPctrical contact with some portion of the skin, nails, mucous membranes, or 11 other body surface. In the case of transdermal agent sampling, one of the two 12 electrodes is referred to as the "receptor" electrode, and is the one into which 13 the agent (e.g., body analyte) is collected after being withdrawn from the body.
14 The second electrode is typically termed the "counter" or "return"
electrode, and serves to close the electrical circuit through the body. For example, when the 16 agent to be sampled is a cation, the cathode becomes the receptor electrode 17 while the anode serves to complete the circuit. When the agent to be sampled 18 is an anion, the anode becomes the receptor electrode while the cathode 19 serves to complete the circuit. When the agent to be sampled has no net charge (e.g., glucose), then either the anode or the cathode, or both electrodes, 21 can serve as the receptor electrode.
22 Figures 6-10 illustrate a representative reverse electrotransport sampling 23 device 10 that may be used in conjunction with the present invention.
Device 24 10 comprises an upper housing 16, a circuit board assembly 18, a lower housing 20, first electrode 22, second electrode 24, electrically conductive gel 26 reservoir 26, electrically conductive gel reservoir 28 and skin-compatible 27 adhesive 30. Upper housing 16 has lateral wings 15 which assist in holding 28 device 10 on a patient's skin. Printed circuit board assembly 18 comprises an 29 integrated circuit 19 coupled to discrete components 40 and battery 32.
Circuit board assembly 18 is attached to housing 16 by posts (not shown in Figure 1) s.
~~~~
1 passing through openings 13a and 13b, the ends of the posts being 2 heated/melted in order to heat stake the circuit board assembly 18 to the 3 housing 16. Lower housing 20 is attached to the upper housing 16 by means 4 of adhesive layer 30, the upper surface 34 of adhesive layer 30 being adhered to both lower housing 20 and upper housing 16 including the bottom surfaces 6 of wings 15. Shown (partially) on the underside of circuit board assembly 18 is 7 a button cell battery 32. Other types of batteries may also be employed to 8 power device 10 depending on the need.
9 The device 10 is generally comprised of battery 32, eiectronic circuitry 19,40, electrodes 22,24, conductive gel reservoirs 26,28, and device 2, all of 11 which are integrated into a self-contained unit. The outputs (not shown in 12 Figure 1) of the circuit board assembly 18 make electrical contact with the 13 electrodes 24 and 22 through openings 23,23 in the depressions 25,25' formed 14 in lower housing 20, by means of electrically conductive adhesive strips 42,42'.
Eiectrodes 22 and 24, in turn, are in direct mechanical and electrical contact 16 with the top sides 44,44 of conductive gel reservoirs 26 and 28. The bottom 17 side 46 of conductive gel reservoir 28 contacts the patient's skin through the 18 opening 29 in adhesive layer 30. The bottom side 46' of conductive gel 19 reservoir 26 contacts the patient's skin through the plurality of openings 8 in the device 2. The gel in reservoir 26 is preferably a viscous gel that fills the 21 openings 8 such that the gel is in contact with the skin when the blades have 22 penetrated the stratum corneum. The contact between the gel and skin 23 provides a path for the agent to be transported along. If the gel is not in direct 24 contact with the skin initially, typically sweat accumulates in the confined area and provides a path for the transport of agent from the skin.
26 Device 10 optionally has a feature which allows the patient to 27 self-administer a sampling or monitoring sequence. Upon depression of push 28 button switch 12, the electronic circuitry on circuit board assembly 18 delivers a 29 predetermined DC current to the electrode/reservoirs 22,26 and 24,28 for a sampling interval of predetermined length. The push button switch 12 is 31 conveniently located on the top side of device 10 and is easily actuated through I clothing. A double press of the push button switch 12 within a short time 2 period, e.g., three seconds, is preferably used to activate the device for a 3 sampling or monitoring sequence, thereby minimizing the likelihood of 4 inadvertent actuation of the device 10. Preferably, the device transmits to the user a visual and/or audible confirmation of the onset of the sampling interval 6 by means of LED 14 becoming lit and/or an audible sound signal from, e.g., a 7 "beeper". Agent is withdrawn through the patient's skin, e.g., on the arm, by 8 electrotransport over the predetermined sampling interval.
s The push button switch 12, the electronic circuitry on circuit board to assembly 18 and the battery 32 are adhesively "sealed" between upper 11 housing 16 and lower housing 20. Upper housing 16 is preferably composed of 12 rubber or other elastomeric material, e.g., injection moldable ethylene vinyl 13 acetate. Lower housing 20 is preferably composed of a plastic or elastomeric 14 sheet rnaterial (e.g., polyethylene) which can be easily molded to form depressions 25,25' and cut to form openings 23,23'. The assembled device 10 16 is preferably water resistant (i.e., splash proof) and is most preferably 17 waterproof. The system has a low profile that easily conforms to the body, 18 thereby allowing freedom of movement at, and around, the wearing site. The 19 reservoirs 26 and 28 are located on the skin-contacting side of the device and are sufficiently separated to prevent accidental electrical shorting during 21 normal handling and use.
22 The device 10 adheres to the patient's body surface (e.g., skin) by 23 means of an adhesive layer 30 (which has upper adhesive side 34 and body-24 contacting adhesive side 36). The adhesive side 36 covers the entire underneath side of the device 10 except where the device 2 and reservoir 28 26 are located. The adhesive side 36 has adhesive properties which assures that 27 the device 10 remains in place on the body during normal user activity, and yet 28 permits reasonable removal after the predetermined (e.g., 24-hour) wear 29 period. Upper adhesive side 34 adheres to lower housing 20 and retains the electrodes and gel reservoirs within housing depression 25,25' as well as 31 retains device 2 to lower housing 20 and lower housing 20 to upper housing 16.
I In one embodiment of the sampling device, there is a release liner (not shown) 2 on the device 10 for maintaining the integrity of the device when it is not in use.
3 In use, the release liner is stripped from the device before the device is applied 4 to the skin.
The preferred form in which an agent is sampled generally determines 6 the type of sampling system to be used. That is, the selection of a "passive"
7 system which samples the agent by diffusion or an electrically powered system 8 which samples the agent by electrotransport will be mostly determined by the 9 form of the agent. For osmotic systems which sample drugs by convective flow carried by a solvent, the agent preferably has sufficient solubility in the carrier õ solvent. It will be appreciated by those working in the field that the present 12 invention can be used in conjunction with a wide variety of osmotic sampling 13 systems, as the invention is not limited to a particular device in this regard.
14 Osmotic devices are disclosed for example in U.S. Patent Nos. 4,756,314 to Eckenhoff et al., 4,340,480 to Eckenhoff, 4,655,766 to Theeuwes et al., and 16 4,753,651 to Eckenhoff. As mentioned above, the member 2 of the present 17 invention can be used with known sampling devices including, but not limited 18 to, reverse iontophoresis, osmosis, passive diffusion, phonophoresis, and 19 suction (i.e., negative pressure).
It will be appreciated by those of ordinary skill in the art that the invention 21 can be embodied in other specific forms without departing from the spirit or 22 essential character thereof. The presently disclosed embodiments are 23 therefore considered in all respects to be illustrative and not restrictive. The 24 scope of the invention is indicated by the appended claims rather than the foregoing description, and all changes which come within the meaning and 26 range of equivalents thereof are intended to be embraced therein.
- "~
Claims (28)
1. A device for piercing the stratum corneum of a body surface to form pathways through which an agent can be withdrawn, comprising:
a sheet having a plurality of microblades formed from the sheet and bent downward therefrom and at least one opening in the sheet adjacent the plurality of microblades;
and a collector on the sheet which withdraws the agent through the pathways and collects said agent.
a sheet having a plurality of microblades formed from the sheet and bent downward therefrom and at least one opening in the sheet adjacent the plurality of microblades;
and a collector on the sheet which withdraws the agent through the pathways and collects said agent.
2. The device of claim 1, wherein the collector is positioned to sample the agent from the body surface through an opening in the sheet.
3. The device of claim 1, wherein the collector is a reverse electrotransport device.
4. The device of claim 1, wherein the collector is a passive diffusion device.
5. The device of claim 1, wherein the collector is an osmotic device.
6. The device of claim 1, wherein the collector comprises:
a semi-permeable membrane positioned across an opening in the sheet; and an absorbent pad on the semi-permeable membrane.
a semi-permeable membrane positioned across an opening in the sheet; and an absorbent pad on the semi-permeable membrane.
7. The device of claim 6, wherein the absorbent pad contains an osmotically active material.
8. The device of claim 1, further comprising an agent sensing element.
9. The device of claim 8, wherein the agent sensing element is a glucose sensor.
10. The device of claim 1, further comprising an activation mechanism such that when activated, the collector performs a collection and monitoring sequence.
11. The device of claim 1, wherein the microblades having a length in the range of about 0.02 mm to about 0.4 mm.
12. A method for transdermally sampling an agent contained in the body of a patient, comprising:
providing a sheet having at least one opening adjacent a plurality of microblades, said microblades formed from the sheet and bent downward therefrom;
forming a plurality of microslits through a stratum corneum of skin of the patient by placing on the skin the sheet to cause said microblades to pierce the stratum corneum; and withdrawing the agent through the microslits and collecting the agent in a reservoir.
providing a sheet having at least one opening adjacent a plurality of microblades, said microblades formed from the sheet and bent downward therefrom;
forming a plurality of microslits through a stratum corneum of skin of the patient by placing on the skin the sheet to cause said microblades to pierce the stratum corneum; and withdrawing the agent through the microslits and collecting the agent in a reservoir.
13. The method of claim 12, including positioning the collector to sample the agent through an opening in the sheet.
14. The method of claim 12, wherein the agent is withdrawn via reverse electrotransport.
15. The method of claim 12, wherein the agent is withdrawn via passive diffusion.
16. The method of claim 12, wherein the agent is withdrawn via osmosis.
17. The method of claim 12, including withdrawing the agent through a semipermeable membrane.
18. The method of claim 12, including sensing the agent collected in the reservoir.
19. The method of claim 12, wherein the agent is selected from the group consisting of body electrolytes, alcohol, glucose, and drugs.
20. The method of claim 12, wherein the agent is glucose.
21. The method of claim 20, including sensing the glucose collected in the reservoir and signaling the patient in response thereto.
22. The device of claim 12, wherein the microblades having a length in the range of about 0.02 mm to about 0.4 mm.
23. A device for piercing the stratum corneum of a body surface to form pathways through which an agent can be withdrawn, comprising:
a sheet having at least one opening adjacent a plurality of microblades extending from the sheet; and a passive diffusion device on the sheet which collects the agent withdrawn through the pathways.
a sheet having at least one opening adjacent a plurality of microblades extending from the sheet; and a passive diffusion device on the sheet which collects the agent withdrawn through the pathways.
24. The device of claim 23, wherein the passive diffusion device includes a membrane which draws the agent from the body surface and a reservoir for containing said agent.
25. A device for piercing the stratum corneum of a body surface to form pathways through which an agent can be withdrawn, comprising:
a sheet having at least one opening adjacent a plurality of microblades extending from the sheet; and an osmotic device on the sheet which collects the agent withdrawn through the pathways.
a sheet having at least one opening adjacent a plurality of microblades extending from the sheet; and an osmotic device on the sheet which collects the agent withdrawn through the pathways.
26. The device of claim 25, wherein the osmotic device includes a membrane which draws the agent from the body surface, an absorbent pad containing an osmotically active material, and a reservoir for containing said agent.
27. A device for piercing the stratum corneum of a body surface to form pathways through which an agent can be withdrawn, comprising:
a sheet forming at least one opening adjacent a plurality of microblades extending from the sheet; and a reverse electrotransport device on the sheet which collects the agent withdrawn through the pathways.
a sheet forming at least one opening adjacent a plurality of microblades extending from the sheet; and a reverse electrotransport device on the sheet which collects the agent withdrawn through the pathways.
28. The device of claim 27, wherein the reverse electrotransport device includes an electrical source connected to a plurality of electrodes and a reservoir for containing the agent, the reservoir being coupled to an electrode.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1999096P | 1996-06-18 | 1996-06-18 | |
US60/019,990 | 1996-06-18 | ||
PCT/US1997/010595 WO1997048441A1 (en) | 1996-06-18 | 1997-06-18 | Device for enhancing transdermal sampling |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2253471A1 CA2253471A1 (en) | 1997-12-24 |
CA2253471C true CA2253471C (en) | 2007-10-30 |
Family
ID=21796163
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002253549A Expired - Fee Related CA2253549C (en) | 1996-06-18 | 1997-06-17 | Device for enhancing transdermal agent delivery or sampling |
CA002257217A Expired - Fee Related CA2257217C (en) | 1996-06-18 | 1997-06-18 | Device for enhancing transdermal agent delivery or sampling |
CA002253471A Expired - Fee Related CA2253471C (en) | 1996-06-18 | 1997-06-18 | Device for enhancing transdermal sampling |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002253549A Expired - Fee Related CA2253549C (en) | 1996-06-18 | 1997-06-17 | Device for enhancing transdermal agent delivery or sampling |
CA002257217A Expired - Fee Related CA2257217C (en) | 1996-06-18 | 1997-06-18 | Device for enhancing transdermal agent delivery or sampling |
Country Status (14)
Country | Link |
---|---|
US (5) | US6219574B1 (en) |
EP (3) | EP0914178B1 (en) |
JP (4) | JP4012252B2 (en) |
AR (2) | AR008242A1 (en) |
AT (3) | ATE234129T1 (en) |
AU (3) | AU3399197A (en) |
CA (3) | CA2253549C (en) |
DE (3) | DE69719761T2 (en) |
DK (3) | DK0914178T3 (en) |
ES (3) | ES2195151T3 (en) |
PT (2) | PT917483E (en) |
TW (1) | TW349872B (en) |
WO (3) | WO1997048440A1 (en) |
ZA (1) | ZA975326B (en) |
Families Citing this family (738)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5593852A (en) * | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
JPH04278450A (en) | 1991-03-04 | 1992-10-05 | Adam Heller | Biosensor and method for analyzing subject |
WO1996037256A1 (en) * | 1995-05-22 | 1996-11-28 | Silicon Microdevices, Inc. | Micromechanical patch for enhancing the delivery of compounds through the skin |
ATE234129T1 (en) * | 1996-06-18 | 2003-03-15 | Alza Corp | DEVICE FOR IMPROVING TRANSDERMAL ADMINISTRATION OF MEDICATIONS OR EXTRACTION OF BODY FLUID |
US6607509B2 (en) * | 1997-12-31 | 2003-08-19 | Medtronic Minimed, Inc. | Insertion device for an insertion set and method of using the same |
US6918901B1 (en) * | 1997-12-10 | 2005-07-19 | Felix Theeuwes | Device and method for enhancing transdermal agent flux |
US6083196A (en) * | 1997-12-11 | 2000-07-04 | Alza Corporation | Device for enhancing transdermal agent flux |
US6322808B1 (en) | 1997-12-11 | 2001-11-27 | Alza Corporation | Device for enhancing transdermal agent flux |
CA2313458C (en) * | 1997-12-11 | 2007-04-17 | Alza Corporation | Device for enhancing transdermal agent flux |
EP1911488A3 (en) | 1997-12-11 | 2008-12-03 | Alza Corporation | Device for enhancing transdermal agent flux |
WO2001070330A2 (en) * | 2000-03-17 | 2001-09-27 | Sontra Medical, Inc. | Non-invasive body fluid sampling and analysis |
ATE308924T1 (en) * | 1998-02-17 | 2005-11-15 | Abbott Lab | DEVICE FOR SAMPLING AND ANALYZING INTERSTITIAL FLUID |
US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
US6391005B1 (en) | 1998-03-30 | 2002-05-21 | Agilent Technologies, Inc. | Apparatus and method for penetration with shaft having a sensor for sensing penetration depth |
US6757560B1 (en) * | 1999-04-09 | 2004-06-29 | Novosis Pharma Ag | Transdermal delivery system (TDS) with electrode network |
US8480580B2 (en) | 1998-04-30 | 2013-07-09 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
US8346337B2 (en) | 1998-04-30 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8974386B2 (en) | 1998-04-30 | 2015-03-10 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US8465425B2 (en) | 1998-04-30 | 2013-06-18 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US9066695B2 (en) | 1998-04-30 | 2015-06-30 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
US6949816B2 (en) | 2003-04-21 | 2005-09-27 | Motorola, Inc. | Semiconductor component having first surface area for electrically coupling to a semiconductor chip and second surface area for electrically coupling to a substrate, and method of manufacturing same |
WO1999058051A1 (en) * | 1998-05-13 | 1999-11-18 | Cygnus, Inc. | Monitoring of physiological analytes |
US6503231B1 (en) * | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
US7922709B2 (en) | 1998-07-13 | 2011-04-12 | Genetronics, Inc. | Enhanced delivery of naked DNA to skin by non-invasive in vivo electroporation |
US6355021B1 (en) * | 1998-07-14 | 2002-03-12 | Maersk Medical A/S | Medical puncturing device |
MXPA01000698A (en) * | 1998-07-21 | 2002-04-08 | Spectrx Inc | System and method for continuous analyte monitoring. |
EP1109594B1 (en) * | 1998-08-31 | 2004-10-27 | Johnson & Johnson Consumer Companies, Inc. | Electrotransport device comprising blades |
US6148232A (en) * | 1998-11-09 | 2000-11-14 | Elecsys Ltd. | Transdermal drug delivery and analyte extraction |
CN1191872C (en) * | 1999-01-28 | 2005-03-09 | 塞托·帕尔斯科技公司 | Delivery of macromolecules into cells |
DE19903876B4 (en) * | 1999-02-01 | 2006-09-28 | Orthogen Gentechnologie Gmbh | Process for the in vitro formation and accumulation of interleukin-1 receptor antagonists |
US6792306B2 (en) * | 2000-03-10 | 2004-09-14 | Biophoretic Therapeutic Systems, Llc | Finger-mounted electrokinetic delivery system for self-administration of medicaments and methods therefor |
US6856821B2 (en) * | 2000-05-26 | 2005-02-15 | Kci Licensing, Inc. | System for combined transcutaneous blood gas monitoring and vacuum assisted wound closure |
US6611707B1 (en) | 1999-06-04 | 2003-08-26 | Georgia Tech Research Corporation | Microneedle drug delivery device |
US6743211B1 (en) * | 1999-11-23 | 2004-06-01 | Georgia Tech Research Corporation | Devices and methods for enhanced microneedle penetration of biological barriers |
US6256533B1 (en) | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
US6379324B1 (en) | 1999-06-09 | 2002-04-30 | The Procter & Gamble Company | Intracutaneous microneedle array apparatus |
US6312612B1 (en) | 1999-06-09 | 2001-11-06 | The Procter & Gamble Company | Apparatus and method for manufacturing an intracutaneous microneedle array |
US6890553B1 (en) | 1999-07-08 | 2005-05-10 | Johnson & Johnson Consumer Companies, Inc. | Exothermic topical delivery device |
AU6076200A (en) | 1999-07-08 | 2001-01-30 | Johnson & Johnson Consumer Companies, Inc. | Exothermic bandage |
US20030078499A1 (en) * | 1999-08-12 | 2003-04-24 | Eppstein Jonathan A. | Microporation of tissue for delivery of bioactive agents |
US7133717B2 (en) | 1999-08-25 | 2006-11-07 | Johnson & Johnson Consumer Companies, Inc. | Tissue electroperforation for enhanced drug delivery and diagnostic sampling |
US7113821B1 (en) | 1999-08-25 | 2006-09-26 | Johnson & Johnson Consumer Companies, Inc. | Tissue electroperforation for enhanced drug delivery |
US6251083B1 (en) | 1999-09-07 | 2001-06-26 | Amira Medical | Interstitial fluid methods and devices for determination of an analyte in the body |
US6623457B1 (en) | 1999-09-22 | 2003-09-23 | Becton, Dickinson And Company | Method and apparatus for the transdermal administration of a substance |
US6835184B1 (en) * | 1999-09-24 | 2004-12-28 | Becton, Dickinson And Company | Method and device for abrading skin |
US6331266B1 (en) | 1999-09-29 | 2001-12-18 | Becton Dickinson And Company | Process of making a molded device |
EP1239916B1 (en) | 1999-12-10 | 2005-11-23 | ALZA Corporation | Device and method for enhancing microprotrusion skin piercing |
ES2239053T3 (en) * | 1999-12-16 | 2005-09-16 | Alza Corporation | DEVICE FOR INCREASING THE TRANSDERMAL FLOW OF SAMPLING SUBSTANCES. |
US7013179B2 (en) | 2000-01-07 | 2006-03-14 | Biowave Corporation | Percutaneous electrode array |
US20080033492A1 (en) * | 2000-01-07 | 2008-02-07 | Biowave Corporation | Electro-therapy method |
US6622035B1 (en) * | 2000-01-21 | 2003-09-16 | Instrumentarium Corp. | Electrode for measurement of weak bioelectrical signals |
US20040054393A1 (en) * | 2000-01-21 | 2004-03-18 | Goran Stemme | Medical electrode |
US7404815B2 (en) | 2000-05-01 | 2008-07-29 | Lifescan, Inc. | Tissue ablation by shear force for sampling biological fluids and delivering active agents |
US6595947B1 (en) | 2000-05-22 | 2003-07-22 | Becton, Dickinson And Company | Topical delivery of vaccines |
US6565532B1 (en) | 2000-07-12 | 2003-05-20 | The Procter & Gamble Company | Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup |
US6537242B1 (en) | 2000-06-06 | 2003-03-25 | Becton, Dickinson And Company | Method and apparatus for enhancing penetration of a member for the intradermal sampling or administration of a substance |
US9717451B2 (en) | 2000-06-08 | 2017-08-01 | Becton, Dickinson And Company | Device for withdrawing or administering a substance and method of manufacturing a device |
US6607513B1 (en) | 2000-06-08 | 2003-08-19 | Becton, Dickinson And Company | Device for withdrawing or administering a substance and method of manufacturing a device |
US6540675B2 (en) | 2000-06-27 | 2003-04-01 | Rosedale Medical, Inc. | Analyte monitor |
US6589202B1 (en) | 2000-06-29 | 2003-07-08 | Becton Dickinson And Company | Method and apparatus for transdermally sampling or administering a substance to a patient |
US6603987B2 (en) * | 2000-07-11 | 2003-08-05 | Bayer Corporation | Hollow microneedle patch |
US6440096B1 (en) | 2000-07-14 | 2002-08-27 | Becton, Dickinson And Co. | Microdevice and method of manufacturing a microdevice |
US6656147B1 (en) | 2000-07-17 | 2003-12-02 | Becton, Dickinson And Company | Method and delivery device for the transdermal administration of a substance |
GB0017999D0 (en) | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
US6749575B2 (en) | 2001-08-20 | 2004-06-15 | Alza Corporation | Method for transdermal nucleic acid sampling |
MXPA03001694A (en) | 2000-08-24 | 2004-11-01 | Johnson & Johnson | Method for transdermal nucleic acid sampling. |
US6690959B2 (en) | 2000-09-01 | 2004-02-10 | Medtronic, Inc. | Skin-mounted electrodes with nano spikes |
BR0113749A (en) * | 2000-09-08 | 2004-06-22 | Alza Corp | Methods to inhibit decrease in transdermal drug flow by inhibiting pathway closure |
GB0022742D0 (en) | 2000-09-15 | 2000-11-01 | Smithkline Beecham Biolog | Vaccine |
WO2002030506A2 (en) | 2000-10-12 | 2002-04-18 | Ink Jet Technology Ltd. | Transdermal method |
RU2278623C2 (en) * | 2000-10-13 | 2006-06-27 | Алза Корпорейшн | Micro-protruding member's holder for power applicator |
MXPA03003301A (en) | 2000-10-13 | 2004-12-13 | Johnson & Johnson | Microblade array impact applicator. |
PL360998A1 (en) * | 2000-10-13 | 2004-09-20 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
US7419481B2 (en) | 2000-10-13 | 2008-09-02 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
US7828827B2 (en) | 2002-05-24 | 2010-11-09 | Corium International, Inc. | Method of exfoliation of skin using closely-packed microstructures |
US7108681B2 (en) * | 2000-10-16 | 2006-09-19 | Corium International, Inc. | Microstructures for delivering a composition cutaneously to skin |
US7131987B2 (en) | 2000-10-16 | 2006-11-07 | Corium International, Inc. | Microstructures and method for treating and conditioning skin which cause less irritation during exfoliation |
PL211151B1 (en) | 2000-10-18 | 2012-04-30 | Glaxosmithkline Biolog Sa | Vaccines |
AU2001297823B2 (en) | 2000-10-26 | 2005-05-12 | Alza Corporation | Transdermal drug delivery devices having coated microprotrusions |
DE10057832C1 (en) * | 2000-11-21 | 2002-02-21 | Hartmann Paul Ag | Blood analysis device has syringe mounted in casing, annular mounting carrying needles mounted behind test strip and being swiveled so that needle can be pushed through strip and aperture in casing to take blood sample |
US8641644B2 (en) | 2000-11-21 | 2014-02-04 | Sanofi-Aventis Deutschland Gmbh | Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means |
US6591133B1 (en) * | 2000-11-27 | 2003-07-08 | Microlin Llc | Apparatus and methods for fluid delivery using electroactive needles and implantable electrochemical delivery devices |
US9302903B2 (en) * | 2000-12-14 | 2016-04-05 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
US6663820B2 (en) * | 2001-03-14 | 2003-12-16 | The Procter & Gamble Company | Method of manufacturing microneedle structures using soft lithography and photolithography |
WO2002074173A1 (en) | 2001-03-16 | 2002-09-26 | Alza Corporation | Method and apparatus for coating skin piercing microprojections |
US6932933B2 (en) * | 2001-03-30 | 2005-08-23 | The Aerospace Corporation | Ultraviolet method of embedding structures in photocerams |
EP1397068A2 (en) | 2001-04-02 | 2004-03-17 | Therasense, Inc. | Blood glucose tracking apparatus and methods |
NZ529029A (en) * | 2001-04-20 | 2005-07-29 | Alza Corp | Microprojection array having a beneficial agent containing coating |
EP3251722B1 (en) * | 2001-04-20 | 2020-06-17 | ALZA Corporation | Microprojection array having a beneficial agent containing coating and method of forming the coating thereon |
US20020193729A1 (en) | 2001-04-20 | 2002-12-19 | Cormier Michel J.N. | Microprojection array immunization patch and method |
US6591124B2 (en) | 2001-05-11 | 2003-07-08 | The Procter & Gamble Company | Portable interstitial fluid monitoring system |
US6790179B2 (en) | 2001-08-01 | 2004-09-14 | Johnson & Johnson Consumer Companies, Inc. | Method of examining and diagnosing skin health |
US6840910B2 (en) | 2001-08-01 | 2005-01-11 | Johnson & Johnson Consumer Companies, Inc. | Method of distributing skin care products |
US6855117B2 (en) | 2001-08-01 | 2005-02-15 | Johnson & Johnson Consumer Companies, Inc. | Method of treating the skin of a subject |
AU2002312380A1 (en) | 2001-06-08 | 2002-12-23 | Becton, Dickinson And Company | Device for manipulating a needle or abrader array |
US9226699B2 (en) | 2002-04-19 | 2016-01-05 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling module with a continuous compression tissue interface surface |
US7041068B2 (en) | 2001-06-12 | 2006-05-09 | Pelikan Technologies, Inc. | Sampling module device and method |
CA2448902C (en) | 2001-06-12 | 2010-09-07 | Pelikan Technologies, Inc. | Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties |
US8337419B2 (en) | 2002-04-19 | 2012-12-25 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7344507B2 (en) | 2002-04-19 | 2008-03-18 | Pelikan Technologies, Inc. | Method and apparatus for lancet actuation |
US7981056B2 (en) | 2002-04-19 | 2011-07-19 | Pelikan Technologies, Inc. | Methods and apparatus for lancet actuation |
US7033371B2 (en) | 2001-06-12 | 2006-04-25 | Pelikan Technologies, Inc. | Electric lancet actuator |
US9427532B2 (en) | 2001-06-12 | 2016-08-30 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US7749174B2 (en) | 2001-06-12 | 2010-07-06 | Pelikan Technologies, Inc. | Method and apparatus for lancet launching device intergrated onto a blood-sampling cartridge |
US9795747B2 (en) * | 2010-06-02 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Methods and apparatus for lancet actuation |
WO2002102273A2 (en) * | 2001-06-20 | 2002-12-27 | Power Paper Ltd. | Adhesive bandage with display |
WO2003007819A1 (en) * | 2001-07-19 | 2003-01-30 | Arkray, Inc. | Piercing device |
US20030028087A1 (en) * | 2001-08-01 | 2003-02-06 | Yuzhakov Vadim Vladimirovich | Devices for analyte concentration determination and methods of using the same |
SE0102736D0 (en) * | 2001-08-14 | 2001-08-14 | Patrick Griss | Side opened out-of-plane microneedles for microfluidic transdermal interfacing and fabrication process of side opened out-of-plane microneedles |
US6881203B2 (en) * | 2001-09-05 | 2005-04-19 | 3M Innovative Properties Company | Microneedle arrays and methods of manufacturing the same |
CA2460063C (en) | 2001-09-12 | 2010-07-20 | Becton, Dickinson And Company | Microneedle-based pen device for drug delivery and method for using same |
US20040087992A1 (en) * | 2002-08-09 | 2004-05-06 | Vladimir Gartstein | Microstructures for delivering a composition cutaneously to skin using rotatable structures |
WO2003024507A2 (en) * | 2001-09-19 | 2003-03-27 | Biovalve Technologies, Inc. | Microneedles, microneedle arrays, and systems and methods relating to same |
US20070179717A1 (en) * | 2001-09-21 | 2007-08-02 | Milliken Gordon L | System and method for management of specimens |
US6830562B2 (en) * | 2001-09-27 | 2004-12-14 | Unomedical A/S | Injector device for placing a subcutaneous infusion set |
WO2003026733A2 (en) * | 2001-09-28 | 2003-04-03 | Biovalve Technologies, Inc. | Microneedle with membrane |
WO2003026732A2 (en) * | 2001-09-28 | 2003-04-03 | Biovalve Technologies, Inc. | Switchable microneedle arrays and systems and methods relating to same |
US6689100B2 (en) | 2001-10-05 | 2004-02-10 | Becton, Dickinson And Company | Microdevice and method of delivering or withdrawing a substance through the skin of an animal |
US20030069482A1 (en) * | 2001-10-09 | 2003-04-10 | Workman Jerome James | Sampling article for determining quantitative and qualitative drug transfer to skin |
US6966880B2 (en) * | 2001-10-16 | 2005-11-22 | Agilent Technologies, Inc. | Universal diagnostic platform |
US7429258B2 (en) * | 2001-10-26 | 2008-09-30 | Massachusetts Institute Of Technology | Microneedle transport device |
US20040120964A1 (en) * | 2001-10-29 | 2004-06-24 | Mikszta John A. | Needleless vaccination using chimeric yellow fever vaccine-vectored vaccines against heterologous flaviviruses |
US20040002121A1 (en) * | 2001-11-06 | 2004-01-01 | Regan Jeffrey F. | High throughput methods and devices for assaying analytes in a fluid sample |
AU2002353444A1 (en) * | 2001-11-07 | 2003-05-19 | Transpharma Medical Ltd. | Integrated transdermal drug delivery system |
US20030199810A1 (en) * | 2001-11-30 | 2003-10-23 | Trautman Joseph Creagan | Methods and apparatuses for forming microprojection arrays |
HUP0402605A2 (en) * | 2001-12-20 | 2005-06-28 | Alza Corporation | Skin-piercing microprojections having piercing depth control |
ITTO20011228A1 (en) * | 2001-12-28 | 2003-06-28 | Cane Srl | DISPOSABLE NEEDLE CONTAINER. |
US20040073175A1 (en) * | 2002-01-07 | 2004-04-15 | Jacobson James D. | Infusion system |
US6908453B2 (en) * | 2002-01-15 | 2005-06-21 | 3M Innovative Properties Company | Microneedle devices and methods of manufacture |
CN100553710C (en) | 2002-02-04 | 2009-10-28 | 贝克顿·迪金森公司 | The apparatus and method of percutaneous transmission or extraction of substance |
US7004928B2 (en) | 2002-02-08 | 2006-02-28 | Rosedale Medical, Inc. | Autonomous, ambulatory analyte monitor or drug delivery device |
US8260393B2 (en) | 2003-07-25 | 2012-09-04 | Dexcom, Inc. | Systems and methods for replacing signal data artifacts in a glucose sensor data stream |
US9247901B2 (en) | 2003-08-22 | 2016-02-02 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
AU2003208296A1 (en) * | 2002-02-12 | 2003-09-04 | Unomedial A/S | Infusion device with needle shield |
US8010174B2 (en) | 2003-08-22 | 2011-08-30 | Dexcom, Inc. | Systems and methods for replacing signal artifacts in a glucose sensor data stream |
US10022078B2 (en) | 2004-07-13 | 2018-07-17 | Dexcom, Inc. | Analyte sensor |
ES2612779T3 (en) * | 2002-03-11 | 2017-05-18 | Nitto Denko Corporation | System of transdermal patches of drug administration, method of manufacture thereof and method of use thereof |
US8116860B2 (en) | 2002-03-11 | 2012-02-14 | Altea Therapeutics Corporation | Transdermal porator and patch system and method for using same |
US9918665B2 (en) | 2002-03-11 | 2018-03-20 | Nitto Denko Corporation | Transdermal porator and patch system and method for using same |
US7047070B2 (en) * | 2002-04-02 | 2006-05-16 | Becton, Dickinson And Company | Valved intradermal delivery device and method of intradermally delivering a substance to a patient |
US6780171B2 (en) | 2002-04-02 | 2004-08-24 | Becton, Dickinson And Company | Intradermal delivery device |
US7115108B2 (en) * | 2002-04-02 | 2006-10-03 | Becton, Dickinson And Company | Method and device for intradermally delivering a substance |
US9248267B2 (en) | 2002-04-19 | 2016-02-02 | Sanofi-Aventis Deustchland Gmbh | Tissue penetration device |
US8360992B2 (en) | 2002-04-19 | 2013-01-29 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7232451B2 (en) | 2002-04-19 | 2007-06-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7297122B2 (en) | 2002-04-19 | 2007-11-20 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7331931B2 (en) | 2002-04-19 | 2008-02-19 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8784335B2 (en) | 2002-04-19 | 2014-07-22 | Sanofi-Aventis Deutschland Gmbh | Body fluid sampling device with a capacitive sensor |
US7892183B2 (en) | 2002-04-19 | 2011-02-22 | Pelikan Technologies, Inc. | Method and apparatus for body fluid sampling and analyte sensing |
US7547287B2 (en) | 2002-04-19 | 2009-06-16 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7229458B2 (en) | 2002-04-19 | 2007-06-12 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8221334B2 (en) | 2002-04-19 | 2012-07-17 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7909778B2 (en) | 2002-04-19 | 2011-03-22 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7901362B2 (en) | 2002-04-19 | 2011-03-08 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7976476B2 (en) | 2002-04-19 | 2011-07-12 | Pelikan Technologies, Inc. | Device and method for variable speed lancet |
US8267870B2 (en) | 2002-04-19 | 2012-09-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling with hybrid actuation |
US9795334B2 (en) | 2002-04-19 | 2017-10-24 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US7491178B2 (en) | 2002-04-19 | 2009-02-17 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US7226461B2 (en) | 2002-04-19 | 2007-06-05 | Pelikan Technologies, Inc. | Method and apparatus for a multi-use body fluid sampling device with sterility barrier release |
US8579831B2 (en) | 2002-04-19 | 2013-11-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for penetrating tissue |
US9314194B2 (en) | 2002-04-19 | 2016-04-19 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
US8372016B2 (en) | 2002-04-19 | 2013-02-12 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for body fluid sampling and analyte sensing |
US7674232B2 (en) | 2002-04-19 | 2010-03-09 | Pelikan Technologies, Inc. | Method and apparatus for penetrating tissue |
US8702624B2 (en) | 2006-09-29 | 2014-04-22 | Sanofi-Aventis Deutschland Gmbh | Analyte measurement device with a single shot actuator |
EP1501567B1 (en) | 2002-05-06 | 2018-02-21 | Becton, Dickinson and Company | Device for controlling drug pharmacokinetics |
GB0210397D0 (en) * | 2002-05-07 | 2002-06-12 | Ferring Bv | Pharmaceutical formulations |
US20030212344A1 (en) * | 2002-05-09 | 2003-11-13 | Vadim Yuzhakov | Physiological sample collection devices and methods of using the same |
US20030143113A2 (en) * | 2002-05-09 | 2003-07-31 | Lifescan, Inc. | Physiological sample collection devices and methods of using the same |
US7060192B2 (en) * | 2002-05-09 | 2006-06-13 | Lifescan, Inc. | Methods of fabricating physiological sample collection devices |
US20030211619A1 (en) * | 2002-05-09 | 2003-11-13 | Lorin Olson | Continuous strip of fluid sampling and testing devices and methods of making, packaging and using the same |
US6945952B2 (en) * | 2002-06-25 | 2005-09-20 | Theraject, Inc. | Solid solution perforator for drug delivery and other applications |
CN1691969A (en) | 2002-07-19 | 2005-11-02 | 3M创新有限公司 | Microneedle devices and microneedle delivery apparatus |
TW200409657A (en) * | 2002-08-08 | 2004-06-16 | Alza Corp | Transdermal vaccine delivery device having coated microprotrusions |
JP2005537057A (en) * | 2002-08-29 | 2005-12-08 | ベクトン・ディキンソン・アンド・カンパニー | Microprojection array and method for delivering substance into tissue using the same |
EP1556124B1 (en) * | 2002-09-02 | 2007-10-31 | Unomedical A/S | An apparatus and a method for adjustment of the length of an infusion tubing |
US20040051019A1 (en) * | 2002-09-02 | 2004-03-18 | Mogensen Lasse Wesseltoft | Apparatus for and a method of adjusting the length of an infusion tube |
AU2003258487A1 (en) * | 2002-09-02 | 2004-03-19 | Unomedical A/S | A device for subcutaneous administration of a medicament to a patient |
ATE419033T1 (en) * | 2002-09-02 | 2009-01-15 | Unomedical As | DEVICE FOR SUBCUTANEOUS ADMINISTRATION OF MEDICATION TO A PATIENT AND ASSOCIATED TUBE |
US20120296233A9 (en) * | 2002-09-05 | 2012-11-22 | Freeman Dominique M | Methods and apparatus for an analyte detecting device |
US8062573B2 (en) * | 2002-09-16 | 2011-11-22 | Theraject, Inc. | Solid micro-perforators and methods of use |
US20040236269A1 (en) | 2002-09-25 | 2004-11-25 | Marchitto Kevin S. | Microsurgical tissue treatment system |
US20040115167A1 (en) * | 2002-09-30 | 2004-06-17 | Michel Cormier | Drug delivery device and method having coated microprojections incorporating vasoconstrictors |
US7244394B2 (en) * | 2002-10-03 | 2007-07-17 | Novartis Ag | Methods and kits for assays of analytes of interest in tears |
EP1590034B1 (en) * | 2002-10-07 | 2014-05-14 | Biovalve Technologies, Inc. | Microneedle array patch |
ATE433775T1 (en) * | 2002-10-11 | 2009-07-15 | Becton Dickinson Co | INSULIN DELIVERY SYSTEM WITH SENSOR |
US7381184B2 (en) | 2002-11-05 | 2008-06-03 | Abbott Diabetes Care Inc. | Sensor inserter assembly |
US7045069B2 (en) * | 2002-11-14 | 2006-05-16 | Gennady Ozeryansky | Microfabrication method based on metal matrix composite technology |
DK200201823A (en) | 2002-11-26 | 2004-05-27 | Maersk Medical As | Connection piece for a hose connection |
US7018345B2 (en) * | 2002-12-06 | 2006-03-28 | Hisamitsu Pharmaceutical Co., Inc. | Iontophoresis system |
AR042815A1 (en) * | 2002-12-26 | 2005-07-06 | Alza Corp | ACTIVE AGENT SUPPLY DEVICE THAT HAS COMPOUND MEMBERS |
US8574895B2 (en) | 2002-12-30 | 2013-11-05 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus using optical techniques to measure analyte levels |
AU2003303597A1 (en) | 2002-12-31 | 2004-07-29 | Therasense, Inc. | Continuous glucose monitoring system and methods of use |
US20040158202A1 (en) * | 2003-02-12 | 2004-08-12 | Soren Jensen | Cover |
US7578954B2 (en) * | 2003-02-24 | 2009-08-25 | Corium International, Inc. | Method for manufacturing microstructures having multiple microelements with through-holes |
US7052652B2 (en) | 2003-03-24 | 2006-05-30 | Rosedale Medical, Inc. | Analyte concentration detection devices and methods |
US20050070819A1 (en) * | 2003-03-31 | 2005-03-31 | Rosedale Medical, Inc. | Body fluid sampling constructions and techniques |
US7070580B2 (en) * | 2003-04-01 | 2006-07-04 | Unomedical A/S | Infusion device and an adhesive sheet material and a release liner |
US20040265351A1 (en) * | 2003-04-10 | 2004-12-30 | Miller Richard L. | Methods and compositions for enhancing immune response |
US7415299B2 (en) * | 2003-04-18 | 2008-08-19 | The Regents Of The University Of California | Monitoring method and/or apparatus |
JP2004343275A (en) * | 2003-05-14 | 2004-12-02 | Murata Mach Ltd | Image processing system and scanner |
ES2347248T3 (en) | 2003-05-30 | 2010-10-27 | Pelikan Technologies Inc. | PROCEDURE AND APPLIANCE FOR FLUID INJECTION. |
WO2004107964A2 (en) | 2003-06-06 | 2004-12-16 | Pelikan Technologies, Inc. | Blood harvesting device with electronic control |
US8066639B2 (en) | 2003-06-10 | 2011-11-29 | Abbott Diabetes Care Inc. | Glucose measuring device for use in personal area network |
WO2006001797A1 (en) | 2004-06-14 | 2006-01-05 | Pelikan Technologies, Inc. | Low pain penetrating |
ES2437565T3 (en) * | 2003-06-30 | 2014-01-13 | Alza Corporation | Formulations for coated microprojections containing non-volatile counterions |
US20050123507A1 (en) * | 2003-06-30 | 2005-06-09 | Mahmoud Ameri | Formulations for coated microprojections having controlled solubility |
UY28398A1 (en) * | 2003-07-02 | 2004-11-08 | Alza Corp | IMMUNIZATION METHOD AND PATCH BY MICROPROJECTION PROVISION |
WO2005007020A2 (en) * | 2003-07-03 | 2005-01-27 | Corium International, Inc. | Wound dressing, ingredient delivery device and iv hold-down, and method relating to same |
US7695239B2 (en) * | 2003-07-14 | 2010-04-13 | Fortrend Engineering Corporation | End effector gripper arms having corner grippers which reorient reticle during transfer |
WO2005007223A2 (en) * | 2003-07-16 | 2005-01-27 | Sasha John | Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations |
US7424318B2 (en) | 2003-12-05 | 2008-09-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7460898B2 (en) * | 2003-12-05 | 2008-12-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7467003B2 (en) * | 2003-12-05 | 2008-12-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
WO2007120442A2 (en) | 2003-07-25 | 2007-10-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US7366556B2 (en) | 2003-12-05 | 2008-04-29 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US20190357827A1 (en) | 2003-08-01 | 2019-11-28 | Dexcom, Inc. | Analyte sensor |
US8275437B2 (en) | 2003-08-01 | 2012-09-25 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7774145B2 (en) | 2003-08-01 | 2010-08-10 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8160669B2 (en) | 2003-08-01 | 2012-04-17 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7494465B2 (en) | 2004-07-13 | 2009-02-24 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7591801B2 (en) | 2004-02-26 | 2009-09-22 | Dexcom, Inc. | Integrated delivery device for continuous glucose sensor |
CA2534823A1 (en) * | 2003-08-04 | 2005-02-24 | Alza Corporation | Method and device for enhancing transdermal agent flux |
US7223248B2 (en) * | 2003-08-13 | 2007-05-29 | Lifescan, Inc. | Packaged medical device with a deployable dermal tissue penetration member |
US20140121989A1 (en) | 2003-08-22 | 2014-05-01 | Dexcom, Inc. | Systems and methods for processing analyte sensor data |
US7920906B2 (en) | 2005-03-10 | 2011-04-05 | Dexcom, Inc. | System and methods for processing analyte sensor data for sensor calibration |
JP2007503876A (en) * | 2003-08-26 | 2007-03-01 | アルザ・コーポレーシヨン | Devices and methods for intradermal cell transplantation |
US7099968B2 (en) * | 2003-09-02 | 2006-08-29 | Intel Corporation | System and method for generating bus requests in advance based on speculation states |
US8353861B2 (en) * | 2003-09-18 | 2013-01-15 | Texmac, Inc. | Applicator for applying functional substances into human skin |
WO2005033659A2 (en) | 2003-09-29 | 2005-04-14 | Pelikan Technologies, Inc. | Method and apparatus for an improved sample capture device |
US9351680B2 (en) | 2003-10-14 | 2016-05-31 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a variable user interface |
JP2007510445A (en) | 2003-10-24 | 2007-04-26 | アルザ・コーポレーシヨン | Pretreatment methods and systems for promoting transdermal drug delivery |
EP1680057A4 (en) * | 2003-10-24 | 2007-10-31 | Alza Corp | Apparatus and method for enhancing transdermal drug delivery |
US8016811B2 (en) | 2003-10-24 | 2011-09-13 | Altea Therapeutics Corporation | Method for transdermal delivery of permeant substances |
WO2005044139A2 (en) * | 2003-10-28 | 2005-05-19 | Alza Corporation | Method and apparatus for reducing the incidence of tobacco use |
CA2543641A1 (en) | 2003-10-31 | 2005-05-19 | Alza Corporation | Self-actuating applicator for microprojection array |
US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
USD914881S1 (en) | 2003-11-05 | 2021-03-30 | Abbott Diabetes Care Inc. | Analyte sensor electronic mount |
US20060036209A1 (en) * | 2003-11-13 | 2006-02-16 | Janardhanan Subramony | System and method for transdermal delivery |
DE10353629A1 (en) * | 2003-11-17 | 2005-06-16 | Lts Lohmann Therapie-Systeme Ag | Device for the transdermal administration of active substances |
WO2005049107A2 (en) * | 2003-11-18 | 2005-06-02 | Nanapass Technologies Ltd. | Enhanced penetration system and method for sliding microneedles |
US9247900B2 (en) | 2004-07-13 | 2016-02-02 | Dexcom, Inc. | Analyte sensor |
EP1713533A4 (en) * | 2003-11-21 | 2008-01-23 | Univ California | Method and/or apparatus for puncturing a surface for extraction, in situ analysis, and/or substance delivery using microneedles |
CA2546723A1 (en) * | 2003-11-21 | 2005-06-09 | Alza Corporation | Ultrasound assisted transdermal vaccine delivery method and system |
JP2007512052A (en) * | 2003-11-28 | 2007-05-17 | アクルックス・ディ・ディ・エス・プロプライエタリー・リミテッド | Rapid transdermal delivery systems and methods |
US8364231B2 (en) | 2006-10-04 | 2013-01-29 | Dexcom, Inc. | Analyte sensor |
US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
US8774886B2 (en) | 2006-10-04 | 2014-07-08 | Dexcom, Inc. | Analyte sensor |
US11633133B2 (en) | 2003-12-05 | 2023-04-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
EP2239567B1 (en) | 2003-12-05 | 2015-09-02 | DexCom, Inc. | Calibration techniques for a continuous analyte sensor |
US8017145B2 (en) * | 2003-12-22 | 2011-09-13 | Conopco, Inc. | Exfoliating personal care wipe article containing an array of projections |
US7822454B1 (en) | 2005-01-03 | 2010-10-26 | Pelikan Technologies, Inc. | Fluid sampling device with improved analyte detecting member configuration |
EP1706026B1 (en) | 2003-12-31 | 2017-03-01 | Sanofi-Aventis Deutschland GmbH | Method and apparatus for improving fluidic flow and sample capture |
GB0402131D0 (en) | 2004-01-30 | 2004-03-03 | Isis Innovation | Delivery method |
US20080312555A1 (en) * | 2004-02-06 | 2008-12-18 | Dirk Boecker | Devices and methods for glucose measurement using rechargeable battery energy sources |
EP1718198A4 (en) | 2004-02-17 | 2008-06-04 | Therasense Inc | Method and system for providing data communication in continuous glucose monitoring and management system |
EP1718452A1 (en) * | 2004-02-23 | 2006-11-08 | 3M Innovative Properties Company | Method of molding for microneedle arrays |
US8808228B2 (en) | 2004-02-26 | 2014-08-19 | Dexcom, Inc. | Integrated medicament delivery device for use with continuous analyte sensor |
WO2005094526A2 (en) * | 2004-03-24 | 2005-10-13 | Corium International, Inc. | Transdermal delivery device |
CA2560784A1 (en) | 2004-03-26 | 2005-10-06 | Unomedical A/S | Infusion set |
US20050271684A1 (en) * | 2004-04-13 | 2005-12-08 | Trautman Joseph C | Apparatus and method for transdermal delivery of multiple vaccines |
WO2006104498A2 (en) * | 2004-04-20 | 2006-10-05 | University Of Rochester | Hydrogel-supported porous semiconductor devices |
BRPI0509788A (en) * | 2004-05-13 | 2007-10-23 | Alza Corp | apparatus and method for transdermal delivery of parathyroid hormone agents |
MXPA06013490A (en) * | 2004-05-19 | 2007-06-12 | Johnson & Johnson | Method and formulation for transdermal delivery of immunologically active agents. |
US8828203B2 (en) | 2004-05-20 | 2014-09-09 | Sanofi-Aventis Deutschland Gmbh | Printable hydrogels for biosensors |
US9820684B2 (en) | 2004-06-03 | 2017-11-21 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
US7315758B2 (en) | 2004-06-03 | 2008-01-01 | Lynntech, Inc. | Transdermal delivery of therapeutic agent |
US9775553B2 (en) | 2004-06-03 | 2017-10-03 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for a fluid sampling device |
CA2572455C (en) | 2004-06-04 | 2014-10-28 | Therasense, Inc. | Diabetes care host-client architecture and data management system |
US20050273075A1 (en) * | 2004-06-08 | 2005-12-08 | Peter Krulevitch | Method for delivering drugs to the adventitia using device having microprojections |
US20050273049A1 (en) * | 2004-06-08 | 2005-12-08 | Peter Krulevitch | Drug delivery device using microprojections |
US7783333B2 (en) | 2004-07-13 | 2010-08-24 | Dexcom, Inc. | Transcutaneous medical device with variable stiffness |
US7640048B2 (en) | 2004-07-13 | 2009-12-29 | Dexcom, Inc. | Analyte sensor |
US20060020192A1 (en) | 2004-07-13 | 2006-01-26 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8565848B2 (en) | 2004-07-13 | 2013-10-22 | Dexcom, Inc. | Transcutaneous analyte sensor |
US8452368B2 (en) | 2004-07-13 | 2013-05-28 | Dexcom, Inc. | Transcutaneous analyte sensor |
US7537590B2 (en) * | 2004-07-30 | 2009-05-26 | Microchips, Inc. | Multi-reservoir device for transdermal drug delivery and sensing |
US20060030811A1 (en) * | 2004-08-03 | 2006-02-09 | Wong Patrick S | Method and device for enhancing transdermal agent flux |
US20060030788A1 (en) * | 2004-08-04 | 2006-02-09 | Daniel Wong | Apparatus and method for extracting bodily fluid utilizing a flat lancet |
US8062250B2 (en) | 2004-08-10 | 2011-11-22 | Unomedical A/S | Cannula device |
US20060058602A1 (en) * | 2004-08-17 | 2006-03-16 | Kwiatkowski Krzysztof C | Interstitial fluid analyzer |
JP2008510486A (en) * | 2004-08-23 | 2008-04-10 | ユーエス スモークレス タバコ カンパニー | Tobacco with diversity |
US20060051403A1 (en) * | 2004-09-08 | 2006-03-09 | James Matriano | Microprojection array with improved skin adhesion and compliance |
CA2580137A1 (en) | 2004-09-22 | 2006-03-30 | Glaxosmithkline Biologicals S.A. | Immunogenic composition |
TW200626177A (en) * | 2004-09-28 | 2006-08-01 | Alza Corp | Method and formulation for stabilizing alum-adsorbed vaccines |
ITPD20040252A1 (en) * | 2004-10-14 | 2005-01-14 | Bidoia Sas Di Gianfranco Bidoi | SURGICAL IRRIGATOR |
JP4416625B2 (en) * | 2004-10-29 | 2010-02-17 | シスメックス株式会社 | Tissue cutting device, tissue cutting auxiliary device and storage container |
AU2005306426B2 (en) * | 2004-11-18 | 2011-04-28 | 3M Innovative Properties Company | Masking method for coating a microneedle array |
CN101060882B (en) * | 2004-11-18 | 2010-06-16 | 3M创新有限公司 | Microneedle array applicator and retainer |
US8057842B2 (en) | 2004-11-18 | 2011-11-15 | 3M Innovative Properties Company | Method of contact coating a microneedle array |
EP1827715B1 (en) | 2004-11-18 | 2013-07-17 | 3M Innovative Properties Company | Method of contact coating a microneedle array |
AU2005306422A1 (en) | 2004-11-18 | 2006-05-26 | 3M Innovative Properties Company | Low-profile microneedle array applicator |
CN100367906C (en) * | 2004-12-08 | 2008-02-13 | 圣美迪诺医疗科技(湖州)有限公司 | Endermic implantating biological sensors |
WO2006061027A2 (en) * | 2004-12-10 | 2006-06-15 | Unomedical A/S | Cannula inserter |
JP5882556B2 (en) * | 2004-12-28 | 2016-03-09 | ナブテスコ株式会社 | Skin needle, skin needle manufacturing apparatus, and skin needle manufacturing method |
US7697967B2 (en) | 2005-12-28 | 2010-04-13 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
US9398882B2 (en) | 2005-09-30 | 2016-07-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor and data processing device |
US8029441B2 (en) | 2006-02-28 | 2011-10-04 | Abbott Diabetes Care Inc. | Analyte sensor transmitter unit configuration for a data monitoring and management system |
US9259175B2 (en) | 2006-10-23 | 2016-02-16 | Abbott Diabetes Care, Inc. | Flexible patch for fluid delivery and monitoring body analytes |
US8613703B2 (en) * | 2007-05-31 | 2013-12-24 | Abbott Diabetes Care Inc. | Insertion devices and methods |
US20090082693A1 (en) * | 2004-12-29 | 2009-03-26 | Therasense, Inc. | Method and apparatus for providing temperature sensor module in a data communication system |
US8571624B2 (en) | 2004-12-29 | 2013-10-29 | Abbott Diabetes Care Inc. | Method and apparatus for mounting a data transmission device in a communication system |
US8512243B2 (en) | 2005-09-30 | 2013-08-20 | Abbott Diabetes Care Inc. | Integrated introducer and transmitter assembly and methods of use |
US9743862B2 (en) | 2011-03-31 | 2017-08-29 | Abbott Diabetes Care Inc. | Systems and methods for transcutaneously implanting medical devices |
US7731657B2 (en) | 2005-08-30 | 2010-06-08 | Abbott Diabetes Care Inc. | Analyte sensor introducer and methods of use |
US20090105569A1 (en) | 2006-04-28 | 2009-04-23 | Abbott Diabetes Care, Inc. | Introducer Assembly and Methods of Use |
US10226207B2 (en) | 2004-12-29 | 2019-03-12 | Abbott Diabetes Care Inc. | Sensor inserter having introducer |
US8333714B2 (en) | 2006-09-10 | 2012-12-18 | Abbott Diabetes Care Inc. | Method and system for providing an integrated analyte sensor insertion device and data processing unit |
US7883464B2 (en) | 2005-09-30 | 2011-02-08 | Abbott Diabetes Care Inc. | Integrated transmitter unit and sensor introducer mechanism and methods of use |
US9788771B2 (en) | 2006-10-23 | 2017-10-17 | Abbott Diabetes Care Inc. | Variable speed sensor insertion devices and methods of use |
US9636450B2 (en) | 2007-02-19 | 2017-05-02 | Udo Hoss | Pump system modular components for delivering medication and analyte sensing at seperate insertion sites |
US9572534B2 (en) | 2010-06-29 | 2017-02-21 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US8652831B2 (en) | 2004-12-30 | 2014-02-18 | Sanofi-Aventis Deutschland Gmbh | Method and apparatus for analyte measurement test time |
WO2006078924A2 (en) * | 2005-01-20 | 2006-07-27 | Epley Medical Llc | Minimally invasive, sustained, intra-tympanic drug delivery system |
TW200640519A (en) * | 2005-02-16 | 2006-12-01 | Alza Corp | Microprojection arrays with improved biocompatibility |
US7985199B2 (en) | 2005-03-17 | 2011-07-26 | Unomedical A/S | Gateway system |
NZ560546A (en) * | 2005-03-21 | 2010-03-26 | Unomedical As | A mounting pad, an adhesive device comprising such mounting pad, and methods of preparing such devices |
JP4793806B2 (en) * | 2005-03-22 | 2011-10-12 | Tti・エルビュー株式会社 | Iontophoresis device |
US8280476B2 (en) * | 2005-03-29 | 2012-10-02 | Arkal Medical, Inc. | Devices, systems, methods and tools for continuous glucose monitoring |
US20080009802A1 (en) * | 2005-04-25 | 2008-01-10 | Danilo Lambino | Method of treating acne with stratum corneum piercing device |
US20070270738A1 (en) * | 2005-04-25 | 2007-11-22 | Wu Jeffrey M | Method of treating ACNE with stratum corneum piercing patch |
US20060253078A1 (en) * | 2005-04-25 | 2006-11-09 | Wu Jeffrey M | Method of treating skin disorders with stratum corneum piercing device |
US8112240B2 (en) | 2005-04-29 | 2012-02-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing leak detection in data monitoring and management systems |
US20060281187A1 (en) | 2005-06-13 | 2006-12-14 | Rosedale Medical, Inc. | Analyte detection devices and methods with hematocrit/volume correction and feedback control |
US7621395B2 (en) * | 2005-06-28 | 2009-11-24 | Unomedical A/S | Packing for infusion set and method of applying an infusion set |
US20070004989A1 (en) * | 2005-06-29 | 2007-01-04 | Parvinder Dhillon | Device for transdermal sampling |
US20070025869A1 (en) * | 2005-07-15 | 2007-02-01 | Gordon John H | Fluid Delivery Device |
US20070078414A1 (en) * | 2005-08-05 | 2007-04-05 | Mcallister Devin V | Methods and devices for delivering agents across biological barriers |
US8386030B2 (en) * | 2005-08-08 | 2013-02-26 | Tti Ellebeau, Inc. | Iontophoresis device |
CN102440785A (en) | 2005-08-31 | 2012-05-09 | 弗吉尼亚大学专利基金委员会 | Sensor signal processing method and sensor signal processing device |
ES2478623T3 (en) * | 2005-09-06 | 2014-07-22 | Theraject, Inc. | Solid solution perforator containing drug particles and / or drug adsorbent particles |
US8518069B2 (en) | 2005-09-07 | 2013-08-27 | Cabochon Aesthetics, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US9358033B2 (en) * | 2005-09-07 | 2016-06-07 | Ulthera, Inc. | Fluid-jet dissection system and method for reducing the appearance of cellulite |
US9011473B2 (en) | 2005-09-07 | 2015-04-21 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
US10548659B2 (en) | 2006-01-17 | 2020-02-04 | Ulthera, Inc. | High pressure pre-burst for improved fluid delivery |
US9486274B2 (en) | 2005-09-07 | 2016-11-08 | Ulthera, Inc. | Dissection handpiece and method for reducing the appearance of cellulite |
EP1924364A1 (en) * | 2005-09-12 | 2008-05-28 | Alza Corporation | Coatable transdermal delivery microprojection assembly |
ATE480278T1 (en) | 2005-09-12 | 2010-09-15 | Unomedical As | INTRODUCTION SYSTEM FOR AN INFUSION SET WITH A FIRST AND SECOND SPRING UNIT |
US20070185432A1 (en) * | 2005-09-19 | 2007-08-09 | Transport Pharmaceuticals, Inc. | Electrokinetic system and method for delivering methotrexate |
US20070066934A1 (en) * | 2005-09-19 | 2007-03-22 | Transport Pharmaceuticals, Inc. | Electrokinetic delivery system and methods therefor |
CN101415368A (en) * | 2005-09-26 | 2009-04-22 | 皇家飞利浦电子股份有限公司 | Substance sampling and/or substance delivery via skin |
WO2007041244A2 (en) | 2005-09-30 | 2007-04-12 | Intuity Medical, Inc. | Multi-site body fluid sampling and analysis cartridge |
US9521968B2 (en) | 2005-09-30 | 2016-12-20 | Abbott Diabetes Care Inc. | Analyte sensor retention mechanism and methods of use |
WO2007038555A1 (en) * | 2005-09-30 | 2007-04-05 | Tti Ellebeau, Inc. | Iontophoretic device and method of delivery of active agents to biological interface |
US8880138B2 (en) | 2005-09-30 | 2014-11-04 | Abbott Diabetes Care Inc. | Device for channeling fluid and methods of use |
US8801631B2 (en) | 2005-09-30 | 2014-08-12 | Intuity Medical, Inc. | Devices and methods for facilitating fluid transport |
EP1928539A1 (en) * | 2005-09-30 | 2008-06-11 | Tti Ellebeau, Inc. | Functionalized microneedles transdermal drug delivery systems, devices, and methods |
US20070083147A1 (en) * | 2005-09-30 | 2007-04-12 | Transcutaneous Technologies Inc. | Iontophoresis apparatus and method to deliver antibiotics to biological interfaces |
US7766829B2 (en) | 2005-11-04 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and system for providing basal profile modification in analyte monitoring and management systems |
US7842008B2 (en) | 2005-11-21 | 2010-11-30 | Becton, Dickinson And Company | Intradermal delivery device |
US7885793B2 (en) | 2007-05-22 | 2011-02-08 | International Business Machines Corporation | Method and system for developing a conceptual model to facilitate generating a business-aligned information technology solution |
USD655807S1 (en) | 2005-12-09 | 2012-03-13 | Unomedical A/S | Medical device |
WO2007076458A1 (en) * | 2005-12-21 | 2007-07-05 | Primegen Biotech Llc | Microinjector chip |
WO2007075614A1 (en) * | 2005-12-21 | 2007-07-05 | 3M Innovative Properties Company | Microneedle devices |
GB0607088D0 (en) | 2006-04-07 | 2006-05-17 | Glaxosmithkline Biolog Sa | Vaccine |
AR058592A1 (en) | 2005-12-22 | 2008-02-13 | Glaxosmithkline Biolog Sa | VACCINE |
RU2419460C2 (en) | 2005-12-23 | 2011-05-27 | Уномедикал А/С | Injection device |
CA2636034A1 (en) | 2005-12-28 | 2007-10-25 | Abbott Diabetes Care Inc. | Medical device insertion |
US11298058B2 (en) | 2005-12-28 | 2022-04-12 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor insertion |
EP1981547B1 (en) | 2005-12-28 | 2015-09-30 | Alza Corporation | Stable therapeutic formulations |
US7658728B2 (en) * | 2006-01-10 | 2010-02-09 | Yuzhakov Vadim V | Microneedle array, patch, and applicator for transdermal drug delivery |
US7736310B2 (en) | 2006-01-30 | 2010-06-15 | Abbott Diabetes Care Inc. | On-body medical device securement |
US8419708B2 (en) | 2006-02-10 | 2013-04-16 | Hisamitsu Pharmaceuticals Co., Inc. | Transdermal drug administration apparatus having microneedles |
US7885698B2 (en) * | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
US7826879B2 (en) | 2006-02-28 | 2010-11-02 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use |
AU2007219546B8 (en) | 2006-02-28 | 2012-07-05 | Unomedical A/S | Inserter for infusion part and infusion part provided with needle protector |
EP1991110B1 (en) * | 2006-03-09 | 2018-11-07 | DexCom, Inc. | Systems and methods for processing analyte sensor data |
JP2009530307A (en) * | 2006-03-15 | 2009-08-27 | アルザ コーポレイション | Device and method for transdermal delivery of parathyroid hormone drugs to prevent or treat osteopenia |
US20100049021A1 (en) * | 2006-03-28 | 2010-02-25 | Jina Arvind N | Devices, systems, methods and tools for continuous analyte monitoring |
US20080154107A1 (en) * | 2006-12-20 | 2008-06-26 | Jina Arvind N | Device, systems, methods and tools for continuous glucose monitoring |
US20090131778A1 (en) * | 2006-03-28 | 2009-05-21 | Jina Arvind N | Devices, systems, methods and tools for continuous glucose monitoring |
KR101541383B1 (en) | 2006-03-30 | 2015-08-03 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | immunogenic composition |
US8226891B2 (en) | 2006-03-31 | 2012-07-24 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods therefor |
US9675290B2 (en) | 2012-10-30 | 2017-06-13 | Abbott Diabetes Care Inc. | Sensitivity calibration of in vivo sensors used to measure analyte concentration |
US8346335B2 (en) | 2008-03-28 | 2013-01-01 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US8140312B2 (en) | 2007-05-14 | 2012-03-20 | Abbott Diabetes Care Inc. | Method and system for determining analyte levels |
US8583205B2 (en) | 2008-03-28 | 2013-11-12 | Abbott Diabetes Care Inc. | Analyte sensor calibration management |
US7630748B2 (en) | 2006-10-25 | 2009-12-08 | Abbott Diabetes Care Inc. | Method and system for providing analyte monitoring |
US9339217B2 (en) | 2011-11-25 | 2016-05-17 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods of use |
US7618369B2 (en) | 2006-10-02 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for dynamically updating calibration parameters for an analyte sensor |
US7801582B2 (en) | 2006-03-31 | 2010-09-21 | Abbott Diabetes Care Inc. | Analyte monitoring and management system and methods therefor |
US8374668B1 (en) | 2007-10-23 | 2013-02-12 | Abbott Diabetes Care Inc. | Analyte sensor with lag compensation |
US8219173B2 (en) | 2008-09-30 | 2012-07-10 | Abbott Diabetes Care Inc. | Optimizing analyte sensor calibration |
US9392969B2 (en) | 2008-08-31 | 2016-07-19 | Abbott Diabetes Care Inc. | Closed loop control and signal attenuation detection |
US7620438B2 (en) | 2006-03-31 | 2009-11-17 | Abbott Diabetes Care Inc. | Method and system for powering an electronic device |
US7653425B2 (en) * | 2006-08-09 | 2010-01-26 | Abbott Diabetes Care Inc. | Method and system for providing calibration of an analyte sensor in an analyte monitoring system |
US8224415B2 (en) | 2009-01-29 | 2012-07-17 | Abbott Diabetes Care Inc. | Method and device for providing offset model based calibration for analyte sensor |
US8473022B2 (en) | 2008-01-31 | 2013-06-25 | Abbott Diabetes Care Inc. | Analyte sensor with time lag compensation |
JP5049268B2 (en) * | 2006-04-07 | 2012-10-17 | 久光製薬株式会社 | Microneedle device and transdermal drug administration device with microneedle |
US9119945B2 (en) * | 2006-04-20 | 2015-09-01 | 3M Innovative Properties Company | Device for applying a microneedle array |
EP2010269A4 (en) * | 2006-04-25 | 2009-06-03 | Alza Corp | Microprojection array application with sculptured microprojections for high drug loading |
US20070293816A1 (en) * | 2006-04-25 | 2007-12-20 | Alza Corporation | Microprojection Array Application with Grouped Microprojections for High Drug Loading |
US20070299388A1 (en) * | 2006-04-25 | 2007-12-27 | Alza Corporation | Microprojection array application with multilayered microprojection member for high drug loading |
US7920907B2 (en) | 2006-06-07 | 2011-04-05 | Abbott Diabetes Care Inc. | Analyte monitoring system and method |
WO2007140783A2 (en) | 2006-06-07 | 2007-12-13 | Unomedical A/S | Inserter for transcutaneous sensor |
MX2008015247A (en) | 2006-06-09 | 2008-12-15 | Unomedical As | Mounting pad. |
US20080015494A1 (en) * | 2006-07-11 | 2008-01-17 | Microchips, Inc. | Multi-reservoir pump device for dialysis, biosensing, or delivery of substances |
KR20090037492A (en) | 2006-08-02 | 2009-04-15 | 우노메디컬 에이/에스 | Cannula and delivery device |
JP2010502267A (en) * | 2006-08-28 | 2010-01-28 | エージェンシー・フォー・サイエンス・テクノロジー・アンド・リサーチ | Microneedle and method for producing microneedle |
JP2010502270A (en) * | 2006-08-29 | 2010-01-28 | アルザ・コーポレーシヨン | Chemical electrotransport with hydration measurements in hydratable reservoirs |
US20080058726A1 (en) * | 2006-08-30 | 2008-03-06 | Arvind Jina | Methods and Apparatus Incorporating a Surface Penetration Device |
US9132031B2 (en) | 2006-09-26 | 2015-09-15 | Zeltiq Aesthetics, Inc. | Cooling device having a plurality of controllable cooling elements to provide a predetermined cooling profile |
US8192474B2 (en) | 2006-09-26 | 2012-06-05 | Zeltiq Aesthetics, Inc. | Tissue treatment methods |
US7831287B2 (en) * | 2006-10-04 | 2010-11-09 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
ES2397714T3 (en) | 2006-10-12 | 2013-03-08 | Glaxosmithkline Biologicals S.A. | Vaccine comprising an oil-in-water emulsion adjuvant |
EP2086582B1 (en) | 2006-10-12 | 2012-11-14 | GlaxoSmithKline Biologicals s.a. | Vaccine comprising an oil in water emulsion adjuvant |
US8135548B2 (en) | 2006-10-26 | 2012-03-13 | Abbott Diabetes Care Inc. | Method, system and computer program product for real-time detection of sensitivity decline in analyte sensors |
EP1917990A1 (en) | 2006-10-31 | 2008-05-07 | Unomedical A/S | Infusion set |
US8332028B2 (en) * | 2006-11-28 | 2012-12-11 | Polyplus Battery Company | Protected lithium electrodes for electro-transport drug delivery |
US7785301B2 (en) * | 2006-11-28 | 2010-08-31 | Vadim V Yuzhakov | Tissue conforming microneedle array and patch for transdermal drug delivery or biological fluid collection |
US20080147186A1 (en) * | 2006-12-14 | 2008-06-19 | Joshi Ashok V | Electrochemical Implant For Delivering Beneficial Agents |
CA2676255C (en) * | 2007-01-22 | 2016-06-07 | Altea Therapeutics Corporation | Transdermal porator and patch system and method for using same |
AU2008209537B2 (en) * | 2007-01-22 | 2013-01-31 | Corium Pharma Solutions, Inc. | Applicators for microneedle arrays |
US8121857B2 (en) | 2007-02-15 | 2012-02-21 | Abbott Diabetes Care Inc. | Device and method for automatic data acquisition and/or detection |
US20080199894A1 (en) | 2007-02-15 | 2008-08-21 | Abbott Diabetes Care, Inc. | Device and method for automatic data acquisition and/or detection |
US8732188B2 (en) | 2007-02-18 | 2014-05-20 | Abbott Diabetes Care Inc. | Method and system for providing contextual based medication dosage determination |
US8930203B2 (en) | 2007-02-18 | 2015-01-06 | Abbott Diabetes Care Inc. | Multi-function analyte test device and methods therefor |
US8123686B2 (en) | 2007-03-01 | 2012-02-28 | Abbott Diabetes Care Inc. | Method and apparatus for providing rolling data in communication systems |
US20080234562A1 (en) * | 2007-03-19 | 2008-09-25 | Jina Arvind N | Continuous analyte monitor with multi-point self-calibration |
CA2683721C (en) | 2007-04-14 | 2017-05-23 | Abbott Diabetes Care Inc. | Method and apparatus for providing dynamic multi-stage signal amplification in a medical device |
EP2146625B1 (en) | 2007-04-14 | 2019-08-14 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
EP2137637A4 (en) | 2007-04-14 | 2012-06-20 | Abbott Diabetes Care Inc | Method and apparatus for providing data processing and control in medical communication system |
US9204827B2 (en) | 2007-04-14 | 2015-12-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
ES2784736T3 (en) | 2007-04-14 | 2020-09-30 | Abbott Diabetes Care Inc | Procedure and apparatus for providing data processing and control in a medical communication system |
EP2146627B1 (en) | 2007-04-14 | 2020-07-29 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in medical communication system |
CA2686093C (en) | 2007-04-16 | 2018-05-08 | Corium International, Inc. | Solvent-cast microneedle arrays containing active |
US8439861B2 (en) | 2007-04-24 | 2013-05-14 | Velcro Industries B.V. | Skin penetrating touch fasteners |
US8747872B2 (en) | 2007-05-02 | 2014-06-10 | The Regents Of The University Of Michigan | Nanoemulsion therapeutic compositions and methods of using the same |
US8456301B2 (en) | 2007-05-08 | 2013-06-04 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US7928850B2 (en) | 2007-05-08 | 2011-04-19 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8461985B2 (en) | 2007-05-08 | 2013-06-11 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods |
US8665091B2 (en) | 2007-05-08 | 2014-03-04 | Abbott Diabetes Care Inc. | Method and device for determining elapsed sensor life |
US8260558B2 (en) | 2007-05-14 | 2012-09-04 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US10002233B2 (en) | 2007-05-14 | 2018-06-19 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8560038B2 (en) | 2007-05-14 | 2013-10-15 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US7996158B2 (en) | 2007-05-14 | 2011-08-09 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8239166B2 (en) | 2007-05-14 | 2012-08-07 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US9125548B2 (en) | 2007-05-14 | 2015-09-08 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8103471B2 (en) | 2007-05-14 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8600681B2 (en) | 2007-05-14 | 2013-12-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8444560B2 (en) | 2007-05-14 | 2013-05-21 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US20080287839A1 (en) | 2007-05-18 | 2008-11-20 | Juniper Medical, Inc. | Method of enhanced removal of heat from subcutaneous lipid-rich cells and treatment apparatus having an actuator |
EP2152350A4 (en) | 2007-06-08 | 2013-03-27 | Dexcom Inc | Integrated medicament delivery device for use with continuous analyte sensor |
US20080312518A1 (en) * | 2007-06-14 | 2008-12-18 | Arkal Medical, Inc | On-demand analyte monitor and method of use |
AU2008266382B2 (en) | 2007-06-20 | 2013-06-27 | Unomedical A/S | A catheter and a method and an apparatus for making such catheter |
JP5680960B2 (en) | 2007-06-21 | 2015-03-04 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | Health care device and method |
CN103251414B (en) | 2007-06-21 | 2017-05-24 | 雅培糖尿病护理公司 | Device for detecting analyte level |
WO2009000825A2 (en) | 2007-06-26 | 2008-12-31 | Glaxosmithkline Biologicals S.A. | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates |
US8160900B2 (en) | 2007-06-29 | 2012-04-17 | Abbott Diabetes Care Inc. | Analyte monitoring and management device and method to analyze the frequency of user interaction with the device |
US20090005824A1 (en) * | 2007-06-29 | 2009-01-01 | Polyplus Battery Company | Electrotransport devices, methods and drug electrode assemblies |
EP2185224A1 (en) | 2007-07-03 | 2010-05-19 | Unomedical A/S | Inserter having bistable equilibrium states |
AU2008274311A1 (en) | 2007-07-10 | 2009-01-15 | Unomedical A/S | Inserter having two springs |
US8523927B2 (en) | 2007-07-13 | 2013-09-03 | Zeltiq Aesthetics, Inc. | System for treating lipid-rich regions |
JP2010533524A (en) | 2007-07-18 | 2010-10-28 | ウノメディカル アクティーゼルスカブ | Insertion device with pivoting action |
US7768386B2 (en) * | 2007-07-31 | 2010-08-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing data processing and control in a medical communication system |
US8834366B2 (en) | 2007-07-31 | 2014-09-16 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte sensor calibration |
EP2178524A4 (en) * | 2007-08-06 | 2013-09-04 | Transderm Inc | Microneedle arrays formed from polymer films |
EP2197532A1 (en) * | 2007-08-06 | 2010-06-23 | Serenity Pharmaceuticals Corporation | Methods and devices for desmopressin drug delivery |
EP3488833A1 (en) | 2007-08-21 | 2019-05-29 | Zeltiq Aesthetics, Inc. | Monitoring the cooling of subcutaneous lipid-rich cells, such as the cooling of adipose tissue |
US20090069740A1 (en) * | 2007-09-07 | 2009-03-12 | Polyplus Battery Company | Protected donor electrodes for electro-transport drug delivery |
DK2205169T3 (en) * | 2007-09-28 | 2017-02-20 | The Queen's Univ Of Belfast | Device and method of conveyance |
US8439940B2 (en) | 2010-12-22 | 2013-05-14 | Cabochon Aesthetics, Inc. | Dissection handpiece with aspiration means for reducing the appearance of cellulite |
EP4098177A1 (en) | 2007-10-09 | 2022-12-07 | DexCom, Inc. | Integrated insulin delivery system with continuous glucose sensor |
WO2009048607A1 (en) | 2007-10-10 | 2009-04-16 | Corium International, Inc. | Vaccine delivery via microneedle arrays |
JP5178132B2 (en) * | 2007-10-11 | 2013-04-10 | キヤノン株式会社 | Image processing system and image processing method |
US20090099427A1 (en) * | 2007-10-12 | 2009-04-16 | Arkal Medical, Inc. | Microneedle array with diverse needle configurations |
US8216138B1 (en) | 2007-10-23 | 2012-07-10 | Abbott Diabetes Care Inc. | Correlation of alternative site blood and interstitial fluid glucose concentrations to venous glucose concentration |
US8377031B2 (en) * | 2007-10-23 | 2013-02-19 | Abbott Diabetes Care Inc. | Closed loop control system with safety parameters and methods |
US8409093B2 (en) | 2007-10-23 | 2013-04-02 | Abbott Diabetes Care Inc. | Assessing measures of glycemic variability |
US20090164239A1 (en) | 2007-12-19 | 2009-06-25 | Abbott Diabetes Care, Inc. | Dynamic Display Of Glucose Information |
US9220678B2 (en) | 2007-12-24 | 2015-12-29 | The University Of Queensland | Coating method |
US7766846B2 (en) | 2008-01-28 | 2010-08-03 | Roche Diagnostics Operations, Inc. | Rapid blood expression and sampling |
CN102007066B (en) | 2008-02-07 | 2013-06-26 | 昆士兰大学 | Patch production |
RU2010137844A (en) | 2008-02-13 | 2012-03-20 | Уномедикал А/С (Dk) | SEAL BETWEEN THE CANULE PART AND BY PASSING A FUEL |
US8157747B2 (en) * | 2008-02-15 | 2012-04-17 | Lary Research & Development, Llc | Single-use indicator for a surgical instrument and a surgical instrument incorporating same |
EP2259816B1 (en) | 2008-02-20 | 2015-10-21 | Unomedical A/S | Insertion device with horizontally moving part |
US20110251602A1 (en) * | 2008-04-01 | 2011-10-13 | The General Hospital Corporation | Method and apparatus for tissue expansion |
US20090259176A1 (en) * | 2008-04-09 | 2009-10-15 | Los Gatos Research, Inc. | Transdermal patch system |
WO2009126942A2 (en) | 2008-04-10 | 2009-10-15 | Abbott Diabetes Care Inc. | Method and system for sterilizing an analyte sensor |
WO2009126900A1 (en) | 2008-04-11 | 2009-10-15 | Pelikan Technologies, Inc. | Method and apparatus for analyte detecting device |
EP2612680B1 (en) | 2008-04-16 | 2018-05-23 | GlaxoSmithKline Biologicals SA | Vaccine |
HUE046050T2 (en) * | 2008-05-21 | 2020-01-28 | Ferring Bv | Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia |
US9381680B2 (en) * | 2008-05-21 | 2016-07-05 | Theraject, Inc. | Method of manufacturing solid solution perforator patches and uses thereof |
US20100286045A1 (en) | 2008-05-21 | 2010-11-11 | Bjarke Mirner Klein | Methods comprising desmopressin |
AU2009250341A1 (en) | 2008-05-23 | 2009-11-26 | The University Of Queensland | Analyte detection using a needle projection patch |
US8924159B2 (en) | 2008-05-30 | 2014-12-30 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
EP2293719B1 (en) | 2008-05-30 | 2015-09-09 | Intuity Medical, Inc. | Body fluid sampling device -- sampling site interface |
US7826382B2 (en) | 2008-05-30 | 2010-11-02 | Abbott Diabetes Care Inc. | Close proximity communication device and methods |
US8591410B2 (en) | 2008-05-30 | 2013-11-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing glycemic control |
JP2011522616A (en) * | 2008-06-04 | 2011-08-04 | セブンス センス バイオシステムズ,インコーポレーテッド | Compositions and methods for single-step diagnosis |
CA2726067C (en) | 2008-06-06 | 2020-10-20 | Intuity Medical, Inc. | Detection meter and mode of operation |
US10383556B2 (en) | 2008-06-06 | 2019-08-20 | Intuity Medical, Inc. | Medical diagnostic devices and methods |
US8996104B2 (en) * | 2008-06-25 | 2015-03-31 | Fe3 Medical, Inc. | Patches and method for the transdermal delivery of a therapeutically effective amount of iron |
WO2010009172A1 (en) | 2008-07-14 | 2010-01-21 | Abbott Diabetes Care Inc. | Closed loop control system interface and methods |
US8202531B2 (en) * | 2008-07-23 | 2012-06-19 | Warsaw Orthopedic, Inc. | Drug depots having one or more anchoring members |
EP2149957B1 (en) * | 2008-07-30 | 2017-06-14 | Harman Becker Automotive Systems GmbH | Priority based power distribution arrangement |
US8622988B2 (en) | 2008-08-31 | 2014-01-07 | Abbott Diabetes Care Inc. | Variable rate closed loop control and methods |
US9943644B2 (en) | 2008-08-31 | 2018-04-17 | Abbott Diabetes Care Inc. | Closed loop control with reference measurement and methods thereof |
US20100057040A1 (en) | 2008-08-31 | 2010-03-04 | Abbott Diabetes Care, Inc. | Robust Closed Loop Control And Methods |
US8734422B2 (en) | 2008-08-31 | 2014-05-27 | Abbott Diabetes Care Inc. | Closed loop control with improved alarm functions |
US10383985B2 (en) * | 2008-09-09 | 2019-08-20 | Oxyband Technologies, Inc. | Methods and apparatus for charging and evacuating a diffusion dressing |
JP5722782B2 (en) | 2008-09-26 | 2015-05-27 | ナノバイオ コーポレーション | Nanoemulsion therapeutic composition and method of use thereof |
US8986208B2 (en) | 2008-09-30 | 2015-03-24 | Abbott Diabetes Care Inc. | Analyte sensor sensitivity attenuation mitigation |
US9326707B2 (en) | 2008-11-10 | 2016-05-03 | Abbott Diabetes Care Inc. | Alarm characterization for analyte monitoring devices and systems |
EP2376089B1 (en) | 2008-11-17 | 2018-03-14 | The Regents of the University of Michigan | Cancer vaccine compositions and methods of using the same |
US8603073B2 (en) | 2008-12-17 | 2013-12-10 | Zeltiq Aesthetics, Inc. | Systems and methods with interrupt/resume capabilities for treating subcutaneous lipid-rich cells |
WO2010072664A1 (en) | 2008-12-22 | 2010-07-01 | Unomedical A/S | Medical device comprising adhesive pad |
CA2944660A1 (en) * | 2008-12-30 | 2010-07-08 | Teva Pharmaceuticals International Gmbh | Electronic control of drug delivery system |
US8103456B2 (en) | 2009-01-29 | 2012-01-24 | Abbott Diabetes Care Inc. | Method and device for early signal attenuation detection using blood glucose measurements |
US9375169B2 (en) | 2009-01-30 | 2016-06-28 | Sanofi-Aventis Deutschland Gmbh | Cam drive for managing disposable penetrating member actions with a single motor and motor and control system |
US20100198034A1 (en) | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
US9041541B2 (en) | 2010-01-28 | 2015-05-26 | Seventh Sense Biosystems, Inc. | Monitoring or feedback systems and methods |
US9119578B2 (en) | 2011-04-29 | 2015-09-01 | Seventh Sense Biosystems, Inc. | Plasma or serum production and removal of fluids under reduced pressure |
US20110105872A1 (en) * | 2009-10-30 | 2011-05-05 | Seventh Sense Biosystems, Inc. | Systems and methods for application to skin and control of actuation, delivery, and/or perception thereof |
US20110105951A1 (en) * | 2009-10-30 | 2011-05-05 | Seventh Sense Biosystems, Inc. | Systems and methods for treating, sanitizing, and/or shielding the skin or devices applied to the skin |
US9033898B2 (en) | 2010-06-23 | 2015-05-19 | Seventh Sense Biosystems, Inc. | Sampling devices and methods involving relatively little pain |
US9295417B2 (en) | 2011-04-29 | 2016-03-29 | Seventh Sense Biosystems, Inc. | Systems and methods for collecting fluid from a subject |
JP6078230B2 (en) | 2009-03-02 | 2017-02-08 | セブンス センス バイオシステムズ,インコーポレーテッド | Techniques and devices related to blood sampling |
US20110172510A1 (en) * | 2010-01-13 | 2011-07-14 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or withdrawal of fluids |
US8781576B2 (en) * | 2009-03-17 | 2014-07-15 | Cardiothrive, Inc. | Device and method for reducing patient transthoracic impedance for the purpose of delivering a therapeutic current |
US8615295B2 (en) | 2009-03-17 | 2013-12-24 | Cardiothrive, Inc. | External defibrillator |
US8617487B2 (en) | 2009-03-25 | 2013-12-31 | Venture Lending & Leasing Vi, Inc. | Saliva sample collection systems |
CN101829396B (en) * | 2009-03-27 | 2013-01-30 | 清华大学 | Micro-needle array chip and percutaneous administration patch using same and preparation method thereof |
WO2010121084A1 (en) | 2009-04-15 | 2010-10-21 | Abbott Diabetes Care Inc. | Analyte monitoring system having an alert |
US20110006458A1 (en) * | 2009-04-24 | 2011-01-13 | Corium International, Inc. | Methods for manufacturing microprojection arrays |
US8821945B2 (en) * | 2009-04-25 | 2014-09-02 | Fe3 Medical, Inc. | Method for transdermal iontophoretic delivery of chelated agents |
US9226701B2 (en) | 2009-04-28 | 2016-01-05 | Abbott Diabetes Care Inc. | Error detection in critical repeating data in a wireless sensor system |
EP2425209A4 (en) | 2009-04-29 | 2013-01-09 | Abbott Diabetes Care Inc | Method and system for providing real time analyte sensor calibration with retrospective backfill |
GB2469839B (en) * | 2009-04-29 | 2014-09-10 | Cook Medical Technologies Llc | Medical instrument |
WO2010127187A1 (en) | 2009-04-29 | 2010-11-04 | Abbott Diabetes Care Inc. | Method and system for providing data communication in continuous glucose monitoring and management system |
EP4066797A1 (en) | 2009-04-30 | 2022-10-05 | Zeltiq Aesthetics, Inc. | Device for removing heat from subcutaneous lipid-rich cells |
WO2010138856A1 (en) | 2009-05-29 | 2010-12-02 | Abbott Diabetes Care Inc. | Medical device antenna systems having external antenna configurations |
WO2010144670A1 (en) * | 2009-06-10 | 2010-12-16 | Medtronic, Inc. | Device and method for monitoring of absolute oxygen saturation and tissue hemoglobin concentration |
CA2765511C (en) | 2009-06-16 | 2015-05-12 | The Regents Of The University Of Michigan | Nanoemulsion vaccines |
US8613892B2 (en) | 2009-06-30 | 2013-12-24 | Abbott Diabetes Care Inc. | Analyte meter with a moveable head and methods of using the same |
ES2776474T3 (en) | 2009-07-23 | 2020-07-30 | Abbott Diabetes Care Inc | Continuous analyte measurement system |
CN102470211B (en) | 2009-07-30 | 2014-05-07 | 犹诺医药有限公司 | Inserter device with horizontal moving part |
WO2011014851A1 (en) | 2009-07-31 | 2011-02-03 | Abbott Diabetes Care Inc. | Method and apparatus for providing analyte monitoring system calibration accuracy |
GB0913681D0 (en) | 2009-08-05 | 2009-09-16 | Glaxosmithkline Biolog Sa | Immunogenic composition |
RU2012108579A (en) | 2009-08-07 | 2013-09-20 | Уномедикал А/С | DELIVERY DEVICE WITH SENSOR AND ONE OR MULTIPLE CANULES |
US9358064B2 (en) | 2009-08-07 | 2016-06-07 | Ulthera, Inc. | Handpiece and methods for performing subcutaneous surgery |
US11096708B2 (en) | 2009-08-07 | 2021-08-24 | Ulthera, Inc. | Devices and methods for performing subcutaneous surgery |
EP3988470B1 (en) | 2009-08-31 | 2023-06-28 | Abbott Diabetes Care Inc. | Displays for a medical device |
CA2765712A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Medical devices and methods |
WO2011026148A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte monitoring system and methods for managing power and noise |
WO2011026147A1 (en) | 2009-08-31 | 2011-03-03 | Abbott Diabetes Care Inc. | Analyte signal processing device and methods |
US20130018279A1 (en) * | 2009-09-01 | 2013-01-17 | Pathway Genomics | "blood sample collection apparatus and kits" |
US9320461B2 (en) | 2009-09-29 | 2016-04-26 | Abbott Diabetes Care Inc. | Method and apparatus for providing notification function in analyte monitoring systems |
WO2011041531A1 (en) | 2009-09-30 | 2011-04-07 | Abbott Diabetes Care Inc. | Interconnect for on-body analyte monitoring device |
US8185181B2 (en) | 2009-10-30 | 2012-05-22 | Abbott Diabetes Care Inc. | Method and apparatus for detecting false hypoglycemic conditions |
WO2011065972A2 (en) * | 2009-11-24 | 2011-06-03 | Seventh Sense Biosystems, Inc. | Patient-enacted sampling technique |
US8919605B2 (en) | 2009-11-30 | 2014-12-30 | Intuity Medical, Inc. | Calibration material delivery devices and methods |
EP2523603A2 (en) * | 2010-01-13 | 2012-11-21 | Seventh Sense Biosystems, Inc. | Sampling device interfaces |
KR20120113788A (en) | 2010-01-25 | 2012-10-15 | 젤티크 애스세틱스, 인코포레이티드. | Home-use applicators for non-invasively removing heat from subcutaneous lipid-rich cells via phase change coolants, and associated devices, systems and methods |
USD924406S1 (en) | 2010-02-01 | 2021-07-06 | Abbott Diabetes Care Inc. | Analyte sensor inserter |
GB201003922D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Conjugation process |
GB201003920D0 (en) | 2010-03-09 | 2010-04-21 | Glaxosmithkline Biolog Sa | Method of treatment |
WO2011112753A1 (en) | 2010-03-10 | 2011-09-15 | Abbott Diabetes Care Inc. | Systems, devices and methods for managing glucose levels |
CA3135001A1 (en) | 2010-03-24 | 2011-09-29 | Abbott Diabetes Care Inc. | Medical device inserters and processes of inserting and using medical devices |
JP2013523233A (en) | 2010-03-30 | 2013-06-17 | ウノメディカル アクティーゼルスカブ | Medical device |
US8965476B2 (en) | 2010-04-16 | 2015-02-24 | Sanofi-Aventis Deutschland Gmbh | Tissue penetration device |
CA2795547A1 (en) * | 2010-04-28 | 2011-11-03 | Inovio Pharmaceuticals, Inc. | Oral mucosal electroporation device and use thereof |
AU2011248108B2 (en) | 2010-05-04 | 2016-05-26 | Corium Pharma Solutions, Inc. | Method and device for transdermal delivery of parathyroid hormone using a microprojection array |
US8658603B2 (en) | 2010-06-16 | 2014-02-25 | The Regents Of The University Of Michigan | Compositions and methods for inducing an immune response |
US8635046B2 (en) | 2010-06-23 | 2014-01-21 | Abbott Diabetes Care Inc. | Method and system for evaluating analyte sensor response characteristics |
WO2011162823A1 (en) | 2010-06-25 | 2011-12-29 | Intuity Medical, Inc. | Analyte monitoring methods and systems |
US10092229B2 (en) | 2010-06-29 | 2018-10-09 | Abbott Diabetes Care Inc. | Calibration of analyte measurement system |
US11064921B2 (en) | 2010-06-29 | 2021-07-20 | Abbott Diabetes Care Inc. | Devices, systems and methods for on-skin or on-body mounting of medical devices |
US9943673B2 (en) | 2010-07-14 | 2018-04-17 | Vaxxas Pty Limited | Patch applying apparatus |
US20120016308A1 (en) | 2010-07-16 | 2012-01-19 | Seventh Sense Biosystems, Inc. | Low-pressure packaging for fluid devices |
US8676338B2 (en) | 2010-07-20 | 2014-03-18 | Zeltiq Aesthetics, Inc. | Combined modality treatment systems, methods and apparatus for body contouring applications |
US20130158482A1 (en) | 2010-07-26 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Rapid delivery and/or receiving of fluids |
WO2012021801A2 (en) | 2010-08-13 | 2012-02-16 | Seventh Sense Biosystems, Inc. | Systems and techniques for monitoring subjects |
EP2603256B1 (en) * | 2010-08-13 | 2015-07-22 | Seventh Sense Biosystems, Inc. | Clinical and/or consumer techniques and devices |
EP2433663A1 (en) | 2010-09-27 | 2012-03-28 | Unomedical A/S | Insertion system |
EP2436412A1 (en) | 2010-10-04 | 2012-04-04 | Unomedical A/S | A sprinkler cannula |
WO2012048168A2 (en) | 2010-10-07 | 2012-04-12 | Abbott Diabetes Care Inc. | Analyte monitoring devices and methods |
US10024510B2 (en) * | 2010-10-26 | 2018-07-17 | Steven G. Hammond | Flexible light emitting diode lighting process and assembly |
EP2992827B1 (en) | 2010-11-09 | 2017-04-19 | Seventh Sense Biosystems, Inc. | Systems and interfaces for blood sampling |
US10722395B2 (en) | 2011-01-25 | 2020-07-28 | Zeltiq Aesthetics, Inc. | Devices, application systems and methods with localized heat flux zones for removing heat from subcutaneous lipid-rich cells |
US10136845B2 (en) | 2011-02-28 | 2018-11-27 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
CA3177983A1 (en) | 2011-02-28 | 2012-11-15 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
GB201103836D0 (en) | 2011-03-07 | 2011-04-20 | Glaxosmithkline Biolog Sa | Conjugation process |
WO2012142502A2 (en) | 2011-04-15 | 2012-10-18 | Dexcom Inc. | Advanced analyte sensor calibration and error detection |
US20130158468A1 (en) | 2011-12-19 | 2013-06-20 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving material with respect to a subject surface |
EP2701600B1 (en) | 2011-04-29 | 2016-06-08 | Seventh Sense Biosystems, Inc. | Delivering and/or receiving fluids |
MX339058B (en) | 2011-05-17 | 2016-05-09 | Glaxosmithkline Biolog Sa | Vaccine against streptococcus pneumoniae. |
EP3750480B1 (en) | 2011-08-03 | 2022-02-02 | Intuity Medical, Inc. | Body fluid sampling arrangement |
US11197689B2 (en) | 2011-10-05 | 2021-12-14 | Unomedical A/S | Inserter for simultaneous insertion of multiple transcutaneous parts |
US8585721B2 (en) * | 2011-10-12 | 2013-11-19 | Covidien Lp | Mesh fixation system |
WO2013053022A1 (en) * | 2011-10-12 | 2013-04-18 | The University Of Queensland | Delivery device |
US10010707B2 (en) | 2011-10-12 | 2018-07-03 | 3M Innovative Properties Company | Integrated microneedle array delivery system |
EP2583715A1 (en) | 2011-10-19 | 2013-04-24 | Unomedical A/S | Infusion tube system and method for manufacture |
US9440051B2 (en) | 2011-10-27 | 2016-09-13 | Unomedical A/S | Inserter for a multiplicity of subcutaneous parts |
US9622691B2 (en) | 2011-10-31 | 2017-04-18 | Abbott Diabetes Care Inc. | Model based variable risk false glucose threshold alarm prevention mechanism |
WO2013066873A1 (en) | 2011-10-31 | 2013-05-10 | Abbott Diabetes Care Inc. | Electronic devices having integrated reset systems and methods thereof |
JP6443802B2 (en) | 2011-11-07 | 2018-12-26 | アボット ダイアベティス ケア インコーポレイテッドAbbott Diabetes Care Inc. | Analyte monitoring apparatus and method |
US9317656B2 (en) | 2011-11-23 | 2016-04-19 | Abbott Diabetes Care Inc. | Compatibility mechanisms for devices in a continuous analyte monitoring system and methods thereof |
US8710993B2 (en) | 2011-11-23 | 2014-04-29 | Abbott Diabetes Care Inc. | Mitigating single point failure of devices in an analyte monitoring system and methods thereof |
EP4344633A2 (en) | 2011-12-11 | 2024-04-03 | Abbott Diabetes Care, Inc. | Analyte sensor methods |
US20150157840A1 (en) * | 2012-06-12 | 2015-06-11 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle Sheet |
EP2890297B1 (en) | 2012-08-30 | 2018-04-11 | Abbott Diabetes Care, Inc. | Dropout detection in continuous analyte monitoring data during data excursions |
US9968306B2 (en) | 2012-09-17 | 2018-05-15 | Abbott Diabetes Care Inc. | Methods and apparatuses for providing adverse condition notification with enhanced wireless communication range in analyte monitoring systems |
WO2014052136A1 (en) | 2012-09-26 | 2014-04-03 | Abbott Diabetes Care Inc. | Method and apparatus for improving lag correction during in vivo measurement of analyte concentration with analyte concentration variability and range data |
US20160128947A1 (en) * | 2012-10-22 | 2016-05-12 | Stc. Unm | Bioadhesive films for local and/or systemic delivery |
KR101819803B1 (en) | 2012-10-24 | 2018-01-17 | 플레이틀렛 타게티드 테라퓨틱스, 엘엘씨 | Platelet targeted treatment |
RU2698095C2 (en) | 2012-12-21 | 2019-08-22 | Кориум Интернэшнл, Инк. | Microarray for therapeutic agent delivery and methods of using |
EP4039236A1 (en) | 2013-02-20 | 2022-08-10 | Cytrellis Biosystems, Inc. | System for tightening a region of skin |
CN105142711B (en) | 2013-03-12 | 2019-01-22 | 考里安国际公司 | Micro-protuberance applicator |
US9844460B2 (en) | 2013-03-14 | 2017-12-19 | Zeltiq Aesthetics, Inc. | Treatment systems with fluid mixing systems and fluid-cooled applicators and methods of using the same |
US9545523B2 (en) | 2013-03-14 | 2017-01-17 | Zeltiq Aesthetics, Inc. | Multi-modality treatment systems, methods and apparatus for altering subcutaneous lipid-rich tissue |
JP6700170B2 (en) * | 2013-03-15 | 2020-05-27 | コリウム, インコーポレイテッド | Microarrays for delivery of therapeutic agents and methods of use |
BR112015022432B1 (en) | 2013-03-15 | 2022-02-15 | Corium, Inc | MICROSTRUCTURE ARRANGEMENT, METHOD FOR MANUFACTURING IT AND LIQUID FORMULATION TO FORM DISSOLUTION MICROSTRUCTURES |
US9474475B1 (en) | 2013-03-15 | 2016-10-25 | Abbott Diabetes Care Inc. | Multi-rate analyte sensor data collection with sample rate configurable signal processing |
US10076285B2 (en) | 2013-03-15 | 2018-09-18 | Abbott Diabetes Care Inc. | Sensor fault detection using analyte sensor data pattern comparison |
CA2903459C (en) | 2013-03-15 | 2024-02-20 | Corium International, Inc. | Multiple impact microprojection applicators and methods of use |
EP2968116A1 (en) | 2013-03-15 | 2016-01-20 | Corium International, Inc. | Microarray with polymer-free microstructures, methods of making, and methods of use |
ES2761580T3 (en) | 2013-03-15 | 2020-05-20 | Corium Inc | Microarrays for therapeutic agent delivery, methods of use and manufacturing methods |
US10433773B1 (en) | 2013-03-15 | 2019-10-08 | Abbott Diabetes Care Inc. | Noise rejection methods and apparatus for sparsely sampled analyte sensor data |
US10279189B2 (en) | 2013-06-14 | 2019-05-07 | Cardiothrive, Inc. | Wearable multiphasic cardioverter defibrillator system and method |
US10149973B2 (en) | 2013-06-14 | 2018-12-11 | Cardiothrive, Inc. | Multipart non-uniform patient contact interface and method of use |
US9833630B2 (en) | 2013-06-14 | 2017-12-05 | Cardiothrive, Inc. | Biphasic or multiphasic pulse waveform and method |
US9616243B2 (en) | 2013-06-14 | 2017-04-11 | Cardiothrive, Inc. | Dynamically adjustable multiphasic defibrillator pulse system and method |
US9907970B2 (en) | 2013-06-14 | 2018-03-06 | Cardiothrive, Inc. | Therapeutic system and method using biphasic or multiphasic pulse waveform |
US9656094B2 (en) | 2013-06-14 | 2017-05-23 | Cardiothrive, Inc. | Biphasic or multiphasic pulse generator and method |
WO2014205412A1 (en) | 2013-06-21 | 2014-12-24 | Intuity Medical, Inc. | Analyte monitoring system with audible feedback |
EP3027263A1 (en) | 2013-07-30 | 2016-06-08 | ZP Opco, Inc. | Low-profile microneedle patch applicator |
AU2014306273B2 (en) | 2013-08-09 | 2019-07-11 | Cytrellis Biosystems, Inc. | Methods and apparatuses for skin treatment using non-thermal tissue ablation |
US9630005B2 (en) | 2013-08-27 | 2017-04-25 | Halo Neuro, Inc. | Method and system for providing electrical stimulation to a user |
US9782585B2 (en) | 2013-08-27 | 2017-10-10 | Halo Neuro, Inc. | Method and system for providing electrical stimulation to a user |
US9486618B2 (en) * | 2013-08-27 | 2016-11-08 | Halo Neuro, Inc. | Electrode system for electrical stimulation |
CN107157479A (en) | 2013-08-27 | 2017-09-15 | 哈洛纽罗公司 | Electrode system for electro photoluminescence |
JP6272333B2 (en) * | 2013-09-06 | 2018-01-31 | 久光製薬株式会社 | Microneedle sheet |
DE102013219432A1 (en) * | 2013-09-26 | 2015-03-26 | Peter Röhr | Blood collection device and method for withdrawing blood |
US10208102B2 (en) | 2013-11-01 | 2019-02-19 | University Of Oslo | Albumin variants and uses thereof |
CA2929126C (en) | 2013-11-13 | 2020-01-07 | University Of Oslo | Outer membrane vesicles and uses thereof |
DK3069138T3 (en) | 2013-11-15 | 2019-04-08 | Univ Oslo Hf | CTL PEPTID EPITOPES AND ANTIGEN-SPECIFIC T-CELLS, METHODS OF RECOGNITION THEREOF, AND APPLICATIONS THEREOF |
EP3082897A4 (en) | 2013-12-19 | 2017-07-26 | Cytrellis Biosystems, Inc. | Methods and devices for manipulating subdermal fat |
US11229382B2 (en) | 2013-12-31 | 2022-01-25 | Abbott Diabetes Care Inc. | Self-powered analyte sensor and devices using the same |
TWI548395B (en) * | 2014-01-28 | 2016-09-11 | 微凸科技股份有限公司 | Transdermal micrneedles continuous monitoring system |
EP3099261A2 (en) | 2014-01-31 | 2016-12-07 | Zeltiq Aesthetics, Inc. | Treating systems for treating cellulite by cooling |
US10959631B2 (en) * | 2014-02-01 | 2021-03-30 | Biocircuit Technologies, Inc. | Neural interfacing device |
CN106061546A (en) * | 2014-02-10 | 2016-10-26 | Lts勒曼治疗系统股份公司 | Microneedle system and method for the production thereof |
EP2905047A1 (en) * | 2014-02-10 | 2015-08-12 | LTS LOHMANN Therapie-Systeme AG | Micro-needle system and method for producing the same |
EP3111987B1 (en) * | 2014-02-27 | 2022-04-20 | Hisamitsu Pharmaceutical Co., Inc. | Microneedle sheet |
US10675176B1 (en) | 2014-03-19 | 2020-06-09 | Zeltiq Aesthetics, Inc. | Treatment systems, devices, and methods for cooling targeted tissue |
USD777338S1 (en) | 2014-03-20 | 2017-01-24 | Zeltiq Aesthetics, Inc. | Cryotherapy applicator for cooling tissue |
US20160279401A1 (en) | 2015-03-27 | 2016-09-29 | Allergan, Inc. | Dissolvable microneedles for skin treatment |
US20170185748A1 (en) | 2014-03-30 | 2017-06-29 | Abbott Diabetes Care Inc. | Method and Apparatus for Determining Meal Start and Peak Events in Analyte Monitoring Systems |
US10952891B1 (en) | 2014-05-13 | 2021-03-23 | Zeltiq Aesthetics, Inc. | Treatment systems with adjustable gap applicators and methods for cooling tissue |
US10935174B2 (en) | 2014-08-19 | 2021-03-02 | Zeltiq Aesthetics, Inc. | Stress relief couplings for cryotherapy apparatuses |
US10568759B2 (en) | 2014-08-19 | 2020-02-25 | Zeltiq Aesthetics, Inc. | Treatment systems, small volume applicators, and methods for treating submental tissue |
ES2944885T3 (en) | 2014-08-29 | 2023-06-26 | Corium Pharma Solutions Inc | Matrix of microstructures for administration of active agents |
US10624843B2 (en) | 2014-09-04 | 2020-04-21 | Corium, Inc. | Microstructure array, methods of making, and methods of use |
CN105455855B (en) * | 2014-09-04 | 2018-05-25 | 微凸科技股份有限公司 | Lactic acid measuring equipment and the method for training adjustment |
WO2016039333A1 (en) * | 2014-09-08 | 2016-03-17 | 株式会社かいわ | Puncture device |
JP5967595B2 (en) * | 2014-09-08 | 2016-08-10 | 株式会社かいわ | Puncture device |
EP3204039B1 (en) | 2014-10-10 | 2022-06-08 | The Regents Of The University Of Michigan | Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease |
AR102547A1 (en) | 2014-11-07 | 2017-03-08 | Takeda Vaccines Inc | VACCINES AGAINST DISEASE OF HANDS, FEET AND MOUTH AND MANUFACTURING METHODS AND THEIR USE |
AU2015252119A1 (en) | 2014-11-07 | 2016-05-26 | Takeda Vaccines, Inc. | Hand, foot, and mouth vaccines and methods of manufacture and use thereof |
JP6906885B2 (en) | 2014-11-14 | 2021-07-21 | ロレアル | Microneedle sheet to reduce wrinkles |
JP2017533774A (en) | 2014-11-14 | 2017-11-16 | サイトレリス バイオシステムズ,インコーポレーテッド | Device and method for skin ablation |
JP6571680B2 (en) | 2014-12-05 | 2019-09-04 | 久光製薬株式会社 | Microneedle device system |
CA2975275C (en) | 2015-02-02 | 2023-08-29 | Vaxxas Pty Limited | Microprojection array applicator and method |
US10647964B2 (en) | 2015-03-05 | 2020-05-12 | Northwestern University | Non-neuroinvasive viruses and uses thereof |
WO2016183493A1 (en) | 2015-05-14 | 2016-11-17 | Abbott Diabetes Care Inc. | Compact medical device inserters and related systems and methods |
US10213139B2 (en) | 2015-05-14 | 2019-02-26 | Abbott Diabetes Care Inc. | Systems, devices, and methods for assembling an applicator and sensor control device |
US10857093B2 (en) | 2015-06-29 | 2020-12-08 | Corium, Inc. | Microarray for delivery of therapeutic agent, methods of use, and methods of making |
EP3319518A4 (en) | 2015-07-10 | 2019-03-13 | Abbott Diabetes Care Inc. | System, device and method of dynamic glucose profile response to physiological parameters |
WO2017045031A1 (en) | 2015-09-18 | 2017-03-23 | Vaxxas Pty Limited | Microprojection arrays with microprojections having large surface area profiles |
WO2017070112A1 (en) | 2015-10-19 | 2017-04-27 | Zeltiq Aesthetics, Inc. | Vascular treatment systems, cooling devices, and methods for cooling vascular structures |
GB201518684D0 (en) | 2015-10-21 | 2015-12-02 | Glaxosmithkline Biolog Sa | Vaccine |
CN108290037B (en) | 2015-10-26 | 2021-10-08 | 福禄神经学公司 | Electrode positioning system and method |
CN108472151B (en) | 2016-01-07 | 2020-10-27 | 斯尔替克美学股份有限公司 | Temperature-dependent adhesion between applicator and skin during tissue cooling |
JP2019511255A (en) | 2016-01-11 | 2019-04-25 | バーンダリ,インク. | Microneedle composition and method of using the same |
WO2017132604A1 (en) * | 2016-01-27 | 2017-08-03 | Undercover Colors, Inc. | Methods and apparatus for detecting compounds in liquids |
CN108778409B (en) | 2016-02-08 | 2022-04-08 | 哈洛纽罗公司 | Method and system for improving provision of electrical stimulation |
US10765552B2 (en) | 2016-02-18 | 2020-09-08 | Zeltiq Aesthetics, Inc. | Cooling cup applicators with contoured heads and liner assemblies |
WO2017143345A1 (en) | 2016-02-19 | 2017-08-24 | Zp Opco, Inc. | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines |
EP3422958A1 (en) | 2016-03-01 | 2019-01-09 | Kitotech Medical, Inc. | Microstructure-based systems, apparatus, and methods for wound closure |
WO2017172920A1 (en) | 2016-03-29 | 2017-10-05 | Cytrellis Biosystems, Inc. | Devices and methods for cosmetic skin resurfacing |
US11382790B2 (en) | 2016-05-10 | 2022-07-12 | Zeltiq Aesthetics, Inc. | Skin freezing systems for treating acne and skin conditions |
US10555831B2 (en) | 2016-05-10 | 2020-02-11 | Zeltiq Aesthetics, Inc. | Hydrogel substances and methods of cryotherapy |
US10682297B2 (en) | 2016-05-10 | 2020-06-16 | Zeltiq Aesthetics, Inc. | Liposomes, emulsions, and methods for cryotherapy |
WO2017201390A1 (en) | 2016-05-19 | 2017-11-23 | The Regents Of The University Of Michigan | Novel adjuvant compositions |
GB201610599D0 (en) | 2016-06-17 | 2016-08-03 | Glaxosmithkline Biologicals Sa | Immunogenic Composition |
US10485443B2 (en) | 2016-06-20 | 2019-11-26 | Halo Neuro, Inc. | Electrical interface system |
US20190184366A1 (en) * | 2016-08-03 | 2019-06-20 | Verndari, Inc. | Microarrays and methods |
CA3037490A1 (en) | 2016-09-21 | 2018-03-29 | Cytrellis Biosystems, Inc. | Devices and methods for cosmetic skin resurfacing |
WO2018096396A1 (en) | 2016-11-22 | 2018-05-31 | University Of Oslo | Albumin variants and uses thereof |
CN115444410A (en) | 2017-01-23 | 2022-12-09 | 雅培糖尿病护理公司 | Applicator and assembly for inserting an in vivo analyte sensor |
KR102401856B1 (en) | 2017-02-17 | 2022-05-26 | 알레간 인코포레이티드 | Microneedle Array with Active Ingredient |
US10525255B2 (en) | 2017-03-08 | 2020-01-07 | Halo Neuro, Inc. | System for electrical stimulation |
WO2018170132A1 (en) | 2017-03-14 | 2018-09-20 | University Of Connecticut | Biodegradable pressure sensor |
US11596330B2 (en) | 2017-03-21 | 2023-03-07 | Abbott Diabetes Care Inc. | Methods, devices and system for providing diabetic condition diagnosis and therapy |
US11278217B2 (en) * | 2017-03-31 | 2022-03-22 | RichHealth Technology Corporation | Transdermal microneedle array patch |
CN110709250B (en) | 2017-03-31 | 2022-10-11 | 瓦克萨斯私人有限公司 | Apparatus and method for coating a surface |
US11076879B2 (en) | 2017-04-26 | 2021-08-03 | Zeltiq Aesthetics, Inc. | Shallow surface cryotherapy applicators and related technology |
EP3639010A4 (en) | 2017-06-13 | 2021-03-17 | Vaxxas Pty Limited | Quality control of substrate coatings |
SG11201912601RA (en) | 2017-06-23 | 2020-01-30 | Nosocomial Vaccine Corp | Immunogenic compositions |
AU2018309562A1 (en) | 2017-08-04 | 2020-02-20 | Vaxxas Pty Limited | Compact high mechanical energy storage and low trigger force actuator for the delivery of microprojection array patches (MAP) |
US11660264B2 (en) | 2017-08-23 | 2023-05-30 | Emergex USA Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches |
EP3672570A1 (en) | 2017-08-23 | 2020-07-01 | Zosano Pharma Corporation | Method of rapidly achieving therapeutic concentrations of zolmitriptan for treatment of migraines and cluster headaches |
EP3678698A1 (en) | 2017-09-07 | 2020-07-15 | University Of Oslo | Vaccine molecules |
WO2019048936A1 (en) | 2017-09-07 | 2019-03-14 | University Of Oslo | Vaccine molecules |
US10524730B2 (en) * | 2017-09-28 | 2020-01-07 | Medtronic Minimed, Inc. | Medical devices with microneedle arrays and methods for operating such medical devices |
CN107874767B (en) * | 2017-10-12 | 2020-11-24 | 杭州博拓生物科技股份有限公司 | Device for detecting analyzed substance in sample |
US11382540B2 (en) | 2017-10-24 | 2022-07-12 | Dexcom, Inc. | Pre-connected analyte sensors |
US11331022B2 (en) | 2017-10-24 | 2022-05-17 | Dexcom, Inc. | Pre-connected analyte sensors |
KR20200085302A (en) | 2017-11-03 | 2020-07-14 | 다케다 백신즈 인코포레이티드 | Zika vaccine and immunogenic composition and methods of use thereof |
JP6920179B2 (en) | 2017-11-15 | 2021-08-18 | 新光電気工業株式会社 | Biological electrode parts and their manufacturing methods |
US10507324B2 (en) | 2017-11-17 | 2019-12-17 | Halo Neuro, Inc. | System and method for individualizing modulation |
GB201721582D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | S aureus antigens and immunogenic compositions |
GB201721576D0 (en) | 2017-12-21 | 2018-02-07 | Glaxosmithkline Biologicals Sa | Hla antigens and glycoconjugates thereof |
US10828500B2 (en) | 2017-12-22 | 2020-11-10 | Cardiothrive, Inc. | External defibrillator |
JP7305311B2 (en) | 2018-05-30 | 2023-07-10 | ロレアル | microneedle sheet |
WO2020005973A1 (en) | 2018-06-25 | 2020-01-02 | Corium, Inc. | Hybrid method of forming microstructure array molds, methods of making microstructure arrays, and methods of use |
US11660265B2 (en) | 2018-06-28 | 2023-05-30 | Emergex USA Corporation | Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches |
JP7335061B2 (en) | 2018-06-29 | 2023-08-29 | ロレアル | Beauty method using microneedle sheet |
JP2020002084A (en) | 2018-06-29 | 2020-01-09 | ロレアル | Cosmetic process using microneedle sheet |
JP2020018327A (en) | 2018-07-17 | 2020-02-06 | ロレアル | Microneedle sheet |
EP3829496A1 (en) | 2018-07-31 | 2021-06-09 | Zeltiq Aesthetics, Inc. | Methods, devices, and systems for improving skin characteristics |
KR20210069673A (en) * | 2018-10-04 | 2021-06-11 | 오니오 에이에스 | Sensor system and method with notification function for continuous wireless monitoring and analysis of temperature of organism |
JP2020099513A (en) | 2018-12-21 | 2020-07-02 | ロレアル | Kit and cosmetic process using microneedle sheet |
US11826495B2 (en) | 2019-03-01 | 2023-11-28 | University Of Connecticut | Biodegradable piezoelectric ultrasonic transducer system |
USD1002852S1 (en) | 2019-06-06 | 2023-10-24 | Abbott Diabetes Care Inc. | Analyte sensor device |
KR20220054583A (en) * | 2019-06-28 | 2022-05-03 | 패스포트 테크놀로지스, 인크. | Methods and systems for controlling energy transfer to a filament device |
JP2021094146A (en) | 2019-12-16 | 2021-06-24 | ロレアル | Cosmetic method using microneedle sheet |
US20210252256A1 (en) * | 2020-02-19 | 2021-08-19 | Ronald J. Berenson | Microstructures to attach appliances to tissues |
WO2021183626A1 (en) | 2020-03-10 | 2021-09-16 | University Of Connecticut | Therapeutic bandage |
FR3113843B1 (en) | 2020-09-07 | 2024-03-15 | Oreal | KIT AND COSMETIC TREATMENT USING A MICRO-NEEDLE SHEET |
WO2021256214A1 (en) | 2020-06-17 | 2021-12-23 | L'oreal | Kit and cosmetic process using microneedle sheet |
USD999913S1 (en) | 2020-12-21 | 2023-09-26 | Abbott Diabetes Care Inc | Analyte sensor inserter |
US20230233667A1 (en) | 2021-09-08 | 2023-07-27 | Affinivax, Inc. | Coronavirus vaccine |
FR3135206A1 (en) | 2022-05-05 | 2023-11-10 | L'oreal | Cosmetic process using microneedle sheet |
FR3139007A1 (en) | 2022-08-23 | 2024-03-01 | L'oreal | COMPOSITION SUITABLE FOR COSMETIC TREATMENTS OF KERATINOUS SUBSTANCE |
Family Cites Families (100)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US946837A (en) | 1908-11-05 | 1910-01-18 | Cordelia L Common | Fountain tonic-applicator. |
US2619962A (en) * | 1948-02-19 | 1952-12-02 | Res Foundation | Vaccination appliance |
FR1133709A (en) | 1955-10-17 | 1957-04-01 | Device intended for the application of new medical treatments | |
US2893392A (en) | 1958-01-08 | 1959-07-07 | American Cyanamid Co | Article of manufacture for intracutaneous injections |
US3072122A (en) | 1959-01-15 | 1963-01-08 | Rosenthal Sol Roy | Package for transcutaneous injection |
US2974787A (en) * | 1960-05-10 | 1961-03-14 | American Cyanamid Co | Single use, prepackaged vaccinator |
US3322121A (en) * | 1965-11-26 | 1967-05-30 | Oscar H Banker | Skin-puncturing unit with a collapsible protective cover |
CH522395A (en) * | 1968-07-26 | 1972-05-15 | Micromedic Systems Inc | Test tube intended for percutaneous and digital blood sampling |
US3675766A (en) | 1970-02-04 | 1972-07-11 | Sol Roy Rosenthal | Multiple puncture injector device |
US3964482A (en) | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
BE795384A (en) * | 1972-02-14 | 1973-08-13 | Ici Ltd | DRESSINGS |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
JPS5029096U (en) * | 1973-07-06 | 1975-04-02 | ||
OA05448A (en) * | 1975-10-16 | 1981-03-31 | Manufrance Manufacture Francai | Multi-penetrating vaccine device. |
US4077407A (en) | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4014334A (en) | 1976-02-02 | 1977-03-29 | Alza Corporation | Laminated osmotic system for dispensing beneficial agent |
US4141359A (en) | 1976-08-16 | 1979-02-27 | University Of Utah | Epidermal iontophoresis device |
US4127118B1 (en) * | 1977-03-16 | 1995-12-19 | Alvaro Latorre | Method of effecting and enhancing an erection |
GB2066376B (en) | 1977-11-09 | 1982-10-20 | Emerit Andre A C | Source of vacuum and device for creating and maintaining a negative pressure in an enclosure |
US4250878A (en) | 1978-11-22 | 1981-02-17 | Motion Control, Inc. | Non-invasive chemical species delivery apparatus and method |
US4383529A (en) | 1980-11-03 | 1983-05-17 | Wescor, Inc. | Iontophoretic electrode device, method and gel insert |
US4340048A (en) | 1981-03-28 | 1982-07-20 | Alza Corporation | Self-driven hypodermic injector |
US5370675A (en) * | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US4753651A (en) | 1982-08-30 | 1988-06-28 | Alza Corporation | Self-driven pump |
USH356H (en) * | 1985-02-27 | 1987-11-03 | Medtronic, Inc. | Epicardial lead having low threshold, low polarization myocardial electrode |
SU1296174A1 (en) * | 1985-06-20 | 1987-03-15 | Устиновский Государственный Медицинский Институт | Apparatus for electrophoresis of medicines |
US4655766A (en) | 1985-08-01 | 1987-04-07 | Alza Corporation | Fluid imbibing pump with self-regulating skin patch |
US4756314A (en) | 1985-10-28 | 1988-07-12 | Alza Corporation | Sweat collection patch |
US4711247A (en) | 1986-04-18 | 1987-12-08 | Henry Fishman | Allergy testing method and apparatus |
US5080646A (en) | 1988-10-03 | 1992-01-14 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
DE3735137A1 (en) * | 1987-10-16 | 1989-05-03 | Siemens Ag | ARRANGEMENT FOR DISPENSING MEDICINES IN AN IMPLANTABLE MEDICAL DEVICE |
JP2907342B2 (en) | 1988-01-29 | 1999-06-21 | ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | Ion infiltration non-invasive sampling or delivery device |
US5362307A (en) | 1989-01-24 | 1994-11-08 | The Regents Of The University Of California | Method for the iontophoretic non-invasive-determination of the in vivo concentration level of an inorganic or organic substance |
US5438984A (en) | 1988-09-08 | 1995-08-08 | Sudor Partners | Apparatus and method for the collection of analytes on a dermal patch |
US5169382A (en) | 1988-10-03 | 1992-12-08 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
US5147296A (en) | 1988-10-03 | 1992-09-15 | Alza Corporation | Membrane for electrotransport transdermal drug delivery |
US4941517A (en) * | 1988-10-20 | 1990-07-17 | Galloway Trust | Aseptic fluid transfer apparatus and methods |
US5054499A (en) | 1989-03-27 | 1991-10-08 | Swierczek Remi D | Disposable skin perforator and blood testing device |
US5139023A (en) * | 1989-06-02 | 1992-08-18 | Theratech Inc. | Apparatus and method for noninvasive blood glucose monitoring |
EP0429842B1 (en) | 1989-10-27 | 1996-08-28 | Korea Research Institute Of Chemical Technology | Device for the transdermal administration of protein or peptide drug |
US5036861A (en) | 1990-01-11 | 1991-08-06 | Sembrowich Walter L | Method and apparatus for non-invasively monitoring plasma glucose levels |
US5161532A (en) | 1990-04-19 | 1992-11-10 | Teknekron Sensor Development Corporation | Integral interstitial fluid sensor |
US5300100A (en) * | 1990-08-22 | 1994-04-05 | Advanced Warming Systems, Inc. | Body warmer |
US5158537A (en) * | 1990-10-29 | 1992-10-27 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
US5279544A (en) * | 1990-12-13 | 1994-01-18 | Sil Medics Ltd. | Transdermal or interdermal drug delivery devices |
US5156591A (en) | 1990-12-13 | 1992-10-20 | S. I. Scientific Innovations Ltd. | Skin electrode construction and transdermal drug delivery device utilizing same |
SE9101022D0 (en) | 1991-01-09 | 1991-04-08 | Paal Svedman | MEDICAL SUSPENSION DEVICE |
US5312456A (en) * | 1991-01-31 | 1994-05-17 | Carnegie Mellon University | Micromechanical barb and method for making the same |
US5122114A (en) * | 1991-02-01 | 1992-06-16 | Board Of Regents, University Of Texas System | Method of using intramedullary catheter |
US5231993A (en) | 1991-11-20 | 1993-08-03 | Habley Medical Technology Corporation | Blood sampler and component tester with guide member |
JP2572823Y2 (en) | 1992-02-13 | 1998-05-25 | 株式会社アドバンス | Simple blood sampler |
US5484399A (en) * | 1992-02-27 | 1996-01-16 | Sloan-Kettering Institute For Cancer Research | Process and device to reduce interstitial fluid pressure in tissue |
US5309909A (en) | 1992-05-22 | 1994-05-10 | Physio-Control Corporation | Combined skin preparation and monitoring electrode |
JPH0670987A (en) | 1992-08-28 | 1994-03-15 | Katsuro Tachibana | Medicine dosing and body liquid taking-out unit and device therefor |
US5300110A (en) * | 1992-10-15 | 1994-04-05 | Angeion Corporation | Dirk-based epicardial defibrillation electrode |
JPH0824680B2 (en) | 1992-10-26 | 1996-03-13 | 日本電気株式会社 | Suction leachate sampling device |
US5702359A (en) * | 1995-06-06 | 1997-12-30 | Genetronics, Inc. | Needle electrodes for mediated delivery of drugs and genes |
JP2630197B2 (en) | 1993-04-28 | 1997-07-16 | 株式会社ニッショー | Blood suction device |
US5582184A (en) | 1993-10-13 | 1996-12-10 | Integ Incorporated | Interstitial fluid collection and constituent measurement |
US5885211A (en) | 1993-11-15 | 1999-03-23 | Spectrix, Inc. | Microporation of human skin for monitoring the concentration of an analyte |
JPH084182A (en) * | 1994-06-17 | 1996-01-09 | Nippon Steel Metal Prod Co Ltd | Anchor member for flat deck plate |
ES2150001T3 (en) | 1994-06-24 | 2000-11-16 | Cygnus Therapeutic Systems | IONTOPHORETICAL SAMPLING DEVICE. |
CA2205444A1 (en) | 1994-12-09 | 1996-06-13 | Novartis Ag | Transdermal system |
WO1996037256A1 (en) | 1995-05-22 | 1996-11-28 | Silicon Microdevices, Inc. | Micromechanical patch for enhancing the delivery of compounds through the skin |
AU5740496A (en) * | 1995-05-22 | 1996-12-11 | General Hospital Corporation, The | Micromechanical device and method for enhancing delivery of compounds through the skin |
US5571162A (en) * | 1995-06-07 | 1996-11-05 | Intermedics, Inc. | Transvenous defibrillation lead with side hooks |
DE19525607A1 (en) * | 1995-07-14 | 1997-01-16 | Boehringer Ingelheim Kg | Transcorneal drug delivery system |
TR199800347T1 (en) | 1995-08-29 | 1998-05-21 | Spectrx, Inc. | Micro-poring of human skin for drug application and monitoring applications. |
US5682233A (en) | 1995-09-08 | 1997-10-28 | Integ, Inc. | Interstitial fluid sampler |
ATE234129T1 (en) * | 1996-06-18 | 2003-03-15 | Alza Corp | DEVICE FOR IMPROVING TRANSDERMAL ADMINISTRATION OF MEDICATIONS OR EXTRACTION OF BODY FLUID |
ES2200187T3 (en) | 1996-07-03 | 2004-03-01 | Altea Therapeutics Corporation | MULTIPLE MECHANICAL MICROPORATION OF THE SKIN OR MUCOSA. |
JP4054381B2 (en) * | 1996-09-17 | 2008-02-27 | デカ・プロダクツ・リミテッド・パートナーシップ | Drug delivery system by transfer |
US6918901B1 (en) * | 1997-12-10 | 2005-07-19 | Felix Theeuwes | Device and method for enhancing transdermal agent flux |
CA2313458C (en) * | 1997-12-11 | 2007-04-17 | Alza Corporation | Device for enhancing transdermal agent flux |
US6322808B1 (en) * | 1997-12-11 | 2001-11-27 | Alza Corporation | Device for enhancing transdermal agent flux |
US6083196A (en) * | 1997-12-11 | 2000-07-04 | Alza Corporation | Device for enhancing transdermal agent flux |
US6022316A (en) * | 1998-03-06 | 2000-02-08 | Spectrx, Inc. | Apparatus and method for electroporation of microporated tissue for enhancing flux rates for monitoring and delivery applications |
US7419481B2 (en) * | 2000-10-13 | 2008-09-02 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
MXPA03003301A (en) * | 2000-10-13 | 2004-12-13 | Johnson & Johnson | Microblade array impact applicator. |
RU2278623C2 (en) * | 2000-10-13 | 2006-06-27 | Алза Корпорейшн | Micro-protruding member's holder for power applicator |
PL360998A1 (en) * | 2000-10-13 | 2004-09-20 | Alza Corporation | Apparatus and method for piercing skin with microprotrusions |
AU2001297823B2 (en) * | 2000-10-26 | 2005-05-12 | Alza Corporation | Transdermal drug delivery devices having coated microprotrusions |
WO2002074173A1 (en) * | 2001-03-16 | 2002-09-26 | Alza Corporation | Method and apparatus for coating skin piercing microprojections |
NZ529029A (en) * | 2001-04-20 | 2005-07-29 | Alza Corp | Microprojection array having a beneficial agent containing coating |
US20030199810A1 (en) * | 2001-11-30 | 2003-10-23 | Trautman Joseph Creagan | Methods and apparatuses for forming microprojection arrays |
HUP0402605A2 (en) * | 2001-12-20 | 2005-06-28 | Alza Corporation | Skin-piercing microprojections having piercing depth control |
EP1554938B1 (en) * | 2002-06-14 | 2007-07-18 | OGAWA & CO., LTD. | Flavor deterioration inhibitor and inhibitor for the generation of citral deterioration smell |
AR042815A1 (en) * | 2002-12-26 | 2005-07-06 | Alza Corp | ACTIVE AGENT SUPPLY DEVICE THAT HAS COMPOUND MEMBERS |
US20050123507A1 (en) * | 2003-06-30 | 2005-06-09 | Mahmoud Ameri | Formulations for coated microprojections having controlled solubility |
CA2543280A1 (en) * | 2003-10-28 | 2005-05-19 | Alza Corporation | Delivery of polymer conjugates of therapeutic peptides and proteins via coated microporjections |
CA2543641A1 (en) * | 2003-10-31 | 2005-05-19 | Alza Corporation | Self-actuating applicator for microprojection array |
KR20070010115A (en) * | 2003-11-13 | 2007-01-22 | 알자 코포레이션 | Composition and apparatus for transdermal delivery |
BRPI0509788A (en) * | 2004-05-13 | 2007-10-23 | Alza Corp | apparatus and method for transdermal delivery of parathyroid hormone agents |
WO2006079019A2 (en) * | 2005-01-21 | 2006-07-27 | Alza Corporation | Therapeutic peptide formulations for coating microneedles with improved stabitity containing at least one counterion |
US20060177494A1 (en) * | 2005-01-31 | 2006-08-10 | Micheal Cormier | Coated microprojections having reduced variability and method for producing same |
TW200640519A (en) * | 2005-02-16 | 2006-12-01 | Alza Corp | Microprojection arrays with improved biocompatibility |
US8374997B2 (en) * | 2005-05-20 | 2013-02-12 | Teradota Us, Inc. | Application code generation and execution with bypass, logging, user restartability and status functionality |
AU2006252342A1 (en) * | 2005-06-02 | 2006-12-07 | Alza Corporation | Method for terminal sterilization of transdermal delivery devices |
CA2612307A1 (en) * | 2005-06-21 | 2007-01-04 | Alza Corporation | Method and device for coating a continuous strip of microprojection members |
-
1997
- 1997-06-17 AT AT97930077T patent/ATE234129T1/en not_active IP Right Cessation
- 1997-06-17 CA CA002253549A patent/CA2253549C/en not_active Expired - Fee Related
- 1997-06-17 AU AU33991/97A patent/AU3399197A/en not_active Abandoned
- 1997-06-17 DE DE69719761T patent/DE69719761T2/en not_active Expired - Lifetime
- 1997-06-17 DK DK97930077T patent/DK0914178T3/en active
- 1997-06-17 ZA ZA9705326A patent/ZA975326B/en unknown
- 1997-06-17 WO PCT/US1997/010516 patent/WO1997048440A1/en active IP Right Grant
- 1997-06-17 JP JP50326698A patent/JP4012252B2/en not_active Expired - Fee Related
- 1997-06-17 US US08/876,989 patent/US6219574B1/en not_active Expired - Lifetime
- 1997-06-17 ES ES97930077T patent/ES2195151T3/en not_active Expired - Lifetime
- 1997-06-17 US US08/877,155 patent/US7184826B2/en not_active Expired - Fee Related
- 1997-06-17 AR ARP970102644A patent/AR008242A1/en unknown
- 1997-06-17 EP EP97930077A patent/EP0914178B1/en not_active Expired - Lifetime
- 1997-06-17 US US08/877,153 patent/US6230051B1/en not_active Expired - Lifetime
- 1997-06-18 JP JP50331298A patent/JP3847790B2/en not_active Expired - Fee Related
- 1997-06-18 DE DE69730971T patent/DE69730971T2/en not_active Expired - Lifetime
- 1997-06-18 EP EP97931254A patent/EP0917483B1/en not_active Expired - Lifetime
- 1997-06-18 PT PT97931254T patent/PT917483E/en unknown
- 1997-06-18 AT AT97932206T patent/ATE277671T1/en not_active IP Right Cessation
- 1997-06-18 AT AT97931254T patent/ATE277670T1/en not_active IP Right Cessation
- 1997-06-18 DE DE69730973T patent/DE69730973T2/en not_active Expired - Fee Related
- 1997-06-18 EP EP97932206A patent/EP0917484B1/en not_active Expired - Lifetime
- 1997-06-18 PT PT97932206T patent/PT917484E/en unknown
- 1997-06-18 AU AU35725/97A patent/AU3572597A/en not_active Abandoned
- 1997-06-18 DK DK97931254T patent/DK0917483T3/en active
- 1997-06-18 JP JP50331398A patent/JP2001507947A/en active Pending
- 1997-06-18 CA CA002257217A patent/CA2257217C/en not_active Expired - Fee Related
- 1997-06-18 WO PCT/US1997/010595 patent/WO1997048441A1/en active IP Right Grant
- 1997-06-18 ES ES97932206T patent/ES2230614T3/en not_active Expired - Lifetime
- 1997-06-18 CA CA002253471A patent/CA2253471C/en not_active Expired - Fee Related
- 1997-06-18 AU AU34933/97A patent/AU3493397A/en not_active Abandoned
- 1997-06-18 ES ES97931254T patent/ES2230611T3/en not_active Expired - Lifetime
- 1997-06-18 WO PCT/US1997/010596 patent/WO1997048442A1/en active IP Right Grant
- 1997-06-18 DK DK97932206T patent/DK0917484T3/en active
- 1997-08-20 TW TW086111935A patent/TW349872B/en not_active IP Right Cessation
-
1998
- 1998-05-26 AR ARP980102437A patent/AR012859A2/en active IP Right Grant
-
1999
- 1999-12-16 US US09/466,819 patent/US6537264B1/en not_active Expired - Lifetime
-
2007
- 2007-01-29 US US11/668,157 patent/US20070118070A1/en not_active Abandoned
- 2007-07-11 JP JP2007181574A patent/JP2007260436A/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2253471C (en) | Device for enhancing transdermal sampling | |
CA2313458C (en) | Device for enhancing transdermal agent flux | |
US6091975A (en) | Minimally invasive detecting device | |
CA2313698C (en) | Device for enhancing transdermal agent flux | |
EP1037687B8 (en) | Device for enhancing transdermal agent flux | |
EP1006868B1 (en) | Minimally invasive detecting device | |
KR100500204B1 (en) | Device and method for enhancing transdermal sampling | |
EP1911488A2 (en) | Device for enhancing transdermal agent flux | |
MXPA00005725A (en) | Device for enhancing transdermal agent flux |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |